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ABSTRACT 
The Ames/Salmonella mutagenicity assay was used to screen pro-
cessed oil shale extracts for potentially carcinogenic chemicals. 
Positive mutagenic activity was detected in organic solvent extracts 
of all four spent shales tested. This result combined with the fact 
that most carcinogens (90 percent) have been detected as mutagens in 
the Ames test, indicates that these extracts contain carcinogens. 
Aqueous extracts of spent shale exhibited marginal or no mutagenic 
response, presumably because the techniques for extracting and con-
centrating trace quantities of these nearly water-insoluble compounds 
are inadequate. 
Several problems which might limit application of the Ames 
assay for environmental screening were also explored. The results of 
assays of one-to-one mixtures of two mutagens which exhibited differ-
ent dose response curves when assayed separately indicated the re-
sponse to the mixture was non-additive. F~rthermore, the response to 
the mixture was determined to be statistically indistinguishable (chi 
square analysis) from the dose response curve of one of the mutagens 
in the majority of cases. This masking effect was found to persist 
for one strong mutagen (benzo(a)pyrene) even when it composed only 10 
percent of the mixture. The effect of various non-toxic solvents on 
the mutagenic response of certain mutagens was also determined. The 
present study showed that the choice of solvent (ethanol, methanol, 
dimethylsulfoxide. p-dioxane) can significantly alter the magnitude of 
the mutagenic response. Certain solvents may also confer a toxicity 
to compounds which are not otherwise toxic when assayed at the same 
concentration in another solvent. 
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INTRODUCTION 
Envlronmental Carcinogens 
The United States is currently assess-
ing the need to regulate technological 
and industrial development in order to 
protect the health of its citizens. Cancer, 
in particular, is of major concern. Through 
institutions such as the National Cancer 
Institute (NCI) and the National Institute of 
Health (NIH), the government is directing a 
national effort to eliminate this disease. 
Research funds are being used to identify the 
causes of cancer, so that it may be prevented 
and to elaborate the mechanisms of tumor 
formation and growth, so that the disease can 
be cured. 
Environmental carcinogenesis, which is 
reported to account for up to 90 percent 
of the cancer mortality in the United States 
(Higginson 1972; Wynder and Mabuchi 1972) is 
receiving a large portion of the research 
attent ion because the opportunit ies for its 
prevention are great. By limiting man's 
exposure to environmental factors contri-
butIng to this disease (natural and man-made 
chemicals, ionizing and nonionizing radia-
tIon, and certain agents related to an 
lndIvldual's life style, e.g. smoking), a 
significant portion of this type of cancer 
could be eliminated. 
One of the more important concerns in 
the area of environmental carcinogenesis has 
been to determine the extent to which drink-
lng water contributes to cancer. The pres-
ence of organic chemical carcinogens in in-
dustrial effluents discharged to rivers which 
are subsequently used for public water 
supplies has been known for sometime (Middle-
ton and Rosen 1956; Hueper and Conway 1964), 
but control efforts have been hampered by 
technical difficulties in detecting the very 
small amounts of these chemicals which can be 
hazardous. Only recently have instrumenta-
tion and analytical techniques become sophis-
t icated enough to detect minute quantities 
of contaminants in drinking water. The use 
of gas chromatography and mass spectroscopy 
(GC/MS) and high pressure liquid chromato-
graphy (HPLC) have allowed the identification 
and quantification of microgram per liter 
levels of carcinogenic contaminants in river 
water (Harrison et a1. 1975; Hites and 
Biemann 1972; Svec et al. 1973; Sheldon and 
Hites 1978) and in treated municipal water 
supplIes (Hueper and Payne 1963; Andelman and 
Suess 1970; EPA 1972; Kleoper and Fairless 
1972; Scheiman et al. 1974; Junk and Stanley 
1975; Kraybill 1975; Glatz et a1. 1978). 
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Because these carcinogenic contaminants 
are present in such low concentrations, their 
effect is not immediate, and people are 
unknowingly exposed to them over a long 
period of time. The effect of a low-dose, 
long-term exposure to these chemicals is only 
beginning to be known. Epidemiologic 
studies are currently used to determine high 
cancer risk areas of the United States. The 
potent ial environmental sources of carcino-
gens in these areas, i nclud ing the dr ink ing 
water source, are surveyed to determine the 
extent to which each source may contribute to 
cancer mortality. Surveys showing a high 
incidence of cancer in populations located 
along the Ohio, Missouri, and Mississippi 
Rivers point to drinking water as a source of 
carcinogens and a potential cause of cancer. 
One example is the statistically significant 
association (using multivariate regres-
sion technIques) between cancer mortality in 
Louisiana and the use of the Mississippi 
River as a source of drinking water (Harris 
1974; Page et a1. 1976). Similar studies 
conducted along the Ohio and Missouri Rivers 
have supported this correlation (Cook and 
Watson 1966; Buncher 1975). 
Waterborne Carcinogens 
Organic chemical carcinogens reach the 
aquatic environment from several sources and 
in a variety of ways. Surface waters may 
receive these pollutants in effluents from 
manufacturing and processing plants and 
sewage treatment plants (Wedgwood and Cooper 
1955), in runoff and erosion from forests 
and agricultural lands (Kraybill 1977), and 
through fallout and rainout of air pollution 
particulates (Andelman and Suess 1970). 
Carcinogens of natural or industrial origin 
adsorbed onto vegetat ion or soil may leach 
into the groundwater as well (Hueper 1960). 
The fate of the polycyclic aromatic 
hydrocarbons (PAH) in aquatic systems .has 
received a great deal of attention due to the 
fact that many are known to be carcinogenic 
to animals and probably to man (Badger 1962; 
Hueper and Conway 1964). Although several 
researchers have suggested the endogenic 
formation of PAH in plants and microorganisms 
(Borneff 1963; Knoor and Schenk 1968; Torna-
bene 1977), the PAH resulting from human 
activities are quantitatively, by far the 
most significant and the sources are relative-
ly easy to trace. 
The major source of PAH pollution in 
freshwater is petroleum and its combustion 
by-products (Blummage 1975; MacKenzie and 
Hunter 1977) which enter the surface water 
systems through dust fall and stormwater 
runoff (Hites and Bieman 1972; Wakeham 
1977). The presence of PAH in freshwater in 
quant ities above background levels therefore 
suggests organic pollution from fuel develop-
ment and use. As a preventive measure, the 
carcinogenic hazard from synthetic fuel 
development, including the oil shale industry 
proposed for the western United States should 
be assessed by determining its potential as a 
source of PAH and other carcinogens. 
There are at least two ways to accom-
plish this objective. One way is to chemical-
ly analyze spent shale leachate and attempt 
to identify compounds which could potentially 
be carcinogenic. The primary indicator of 
carcinogenic PAH in the environment has 
historically been benzo(a)pyrene (BaP). The 
concentration of BaP in a substance or 
complex mixture has also been used to predict 
its carcinogenic potent ial. The reasons for 
this practice are clear: BaP was early known 
to be a potent animal carcinogen, it was 
easIly identified by its fluorescence spec-
trum, and it was detected in the first 
substances identified as human carcinogens 
(soot, paraffin, oil). Therefore, inventories 
of PAH in the environment emphasize the 
presence of SaP (see Andelmann and Suess 
1970; Suess 1967, 1972). 
The more recent advent of sophisticated 
techniques and instrumentation (GC/MS, HPLC) 
has allowed researchers to determine directly 
the composItion of PAH in a substance and 
lead to the findings that the concentrat ion" 
of BaP is not always related to that of other 
carcinogenic PAH, nor can it account for the 
carcinogenic potency of that material. 
Despite this problem, the chemical approach 
offers information regarding the variety of 
compounds present and has been pursued with 
relatively good success by colleagues at UWRL 
(Maase and Adams 1980). 
An alternate method to assess the 
carcinogenic potent ial of spent shale 
extracts is by the use of bioassays. A 
sensit ive organism can be found to give 
an integrated response of the hazard from 
spent shale. Th is is the approach taken by 
the present study, the objectives of which 
were to: 1) obtain an appropriate bioassay 
to assess the carcinogenic potential of spent 
shale leachates, 2) perform the bioassays, 
and 3) speculate as to the carcinogenic 
hazard of spent shale in light of the va-
lidity of the chosen bioassay. 
Water Pollution Potential of 
Spent oil Shale 
Much attention has been directed toward 
the problem of minimizing the environmental 
impact of processed (spent) shale disposal. 
Trace quantities of heavy metals, salts, and 
residual organics adsorbed onto the shale 
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part icles become a cons iderable problem when 
put into the perspect ive of the quant ity of 
processed shale that will be produced (over 1 
ton of spent shale per barrel of shale o~lt 
Schmidt-Collerus et al. 1976). This, in 
addItIon to the fact that the shale expands 
after processing and is generally disposed of 
above ground where it will be subjected to 
physical and chemical weathering thus allow-
ing the contaminants to leach out, explains 
the necess ity for determining the potent ial 
impact on the biological system. The present 
study was init iated to assess the carcino-
genic potent ial of spent shale leachate. 
The evaluation of the carcinogenic 
potential of materials implicated in epidemi-
ological studies customarily involves two 
steps: 1) chemical analysis to determine the 
presence of carcinogenic materials (usually 
only BaP as an Indicator of PAH, though the 
presence of other carcinogens is determined 
with less frequency), and 2) bioassays, 
involving extended contact of test animals 
(mice, rats, and hamsters) with suspected 
carcinogenic materials (Atwood and Coomes 
1974). Chemical analyses are usually 
performed prior to bioassays as a screening 
procedure because bioassays are expensive and 
time consuming; however, the bioassays serve 
as the ultimate test for animal carcino-
genes IS. 
Since the BaP content of spent shale is 
low (approximately three orders of magnitude 
lower than that of raw shale oil (Schmidt-
Collerus 1974», it was judged (Atwood and 
Coomes 1974) to be an insignificant source of 
environmental carcinogens and therefore to 
pose no threat to health. Other reasons for 
this judgment included: the lack of certain 
known accelerators of carcinogenic potency 
(hematite and asbestos) in spent shale; the 
similarity in composition of organic material 
in processed shale and that in raw shale 
which is thought to be non-hazardous; and the 
physical and chemical similarity of processed 
shale to carbon black, a material found to be 
a non-carcinogen by animal testing but shown 
to contain carcinogens when chemically 
analyzed (Atwood and Coomes 1974). 
Despite these speculations about the 
carcinogenic nature of shale, a series of 
animal bioassays were performed (Schmidt-
Collerus 1974) to test the tumorigenicity of 
spent shale. The bioassay procedure in use 
at this time involved the repeated applica-
tion of the suspected compound, dissolved in 
an appropriate solvent, to the shaved skin of 
the laboratory rodent. Th is procedure had 
to be modified to simulate the exposure that 
humans might have with the solid shale 
material (breathing and ingesting aerosols). 
The spent shale was mixed in the laboratory 
animals' bedding material so that intimate 
contact could be maintained with the skin and 
respiratory and digestive tracts of the 
experimental animal (hairless rats). The 
results indicated that life-long contact with 
spent shale did not significantly increase 
the frequency of tumor formation (Schmidt-
Collerus 1974). 
The conclusions of this bioassay were 
that spent shale is non-hazardous. The 
results of this experiment also contributed 
to the accumulating evidence against the 
validity of using BaP concentration as an 
indicator of carcinogenicity. For many 
substances neither the composition of carcino-
genic PAH, nor the carcinogenic potency, can 
be predicted by knowing the BaP content. For 
example, in the aquatic environment BaP 
accounts for between 1 and 20 percent of the 
total carcinogenic PAH (Andelman and Suess 
1970). The carcinogenic activity of certain 
petroleum products can be greater or less 
than that which could be accounted for by the 
BaP content. The carcinogenic potent ial of 
various crude shale oils was found to be only 
partly attributable to the BaP content 
(Hueper and Cahnman 1958). Wallcave and 
coworkers (1971) came to a similar conclusion 
regarding the skin tumorigenesis of asphalts 
and coal-tar pitches. The presence of 
non-carcinogenic PAH promoters enhanced the 
carcinogenicity of coal-tar pitch. Finally, 
the discovery that BaP is present in sub-
stances considered to be non-hazardous, such 
as plant material (oak leaves, coconut and 
peanut oils) and soil (Coomes 1976), presum-
ably as a result of biosynthesis, has made 
the prediction of carcinogenic potential 
based on BaP content even more tenuous. 
How does one explaIn the presence of 
carcinogenic compounds yet the lack of 
carcinogenic hazard in ~ubstances such as 
spent shale? It has been suggested that 
either tumor promoter compounds are lack ing 
in that substance or that the carcinogens are 
physically unavailable for metabolism (a 
prerequisite for tumor initiation) (Coomes 
1976). The evidence tends to refute the 
first hypothesis. The carcinogens, BaP and 
dimethlybenz(a)anthracene (DMBA), present in 
benzene extracts of shale, have been deter-
mined to be "complete carcinogens"; once 
metabolized, these compounds can affect tumor 
initIation and promotion (Berenblum 1941; 
Mottram 1944). In addit ion, certain of the 
PAH contaIned in the benzene extract of spent 
shale (e.g. fluoranthene, pyrene, and benzo-
(e)pyrene) while not known to initiate 
tumors, have been found to promote tumor 
growth (Hoffmann and Wynder 1962; Van Duuren 
et a1. 1973; Hoffmann et a1. 1976, 1978). 
The majority of the evidence seems to 
support the hypothes is of phys ical unava il-
ability. Benzo(a)pyrene, and probably other 
carcinogens, are bound up in a structure 
and/or chemica 1 form wh ich renders them 
inactive. The strong adsorbent property of 
finely divided carbon black and spent shale 
has previously been used to explain their 
lack of carcinogenic potential when assayed 
in solid form despite the fact that benzene 
extracts of these substances contain PAH and 
exhibit carcinogenicity in experimental 
animals (Schmidt-Collerus et al. 1976; Nau et 
al.1962). The extraction of carcinogens in 
these substances requires intense physical 
and chemical treatment (reflux ing in an 
organic solvent) and may indicate the pres-
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ence of strong physical or chemical bonds 
that complex the PAH to the spent shale. A 
process wh ich weakens these interact ions 
(soxhlet extraction in the laboratory, or 
phys ical and chemica I weather ing in the 
field) could release these compounds into the 
environment where they would be available 
for biological uptake and accumulation, 
metabolism. or elimination. 
The research conducted by Schmidt-
Collerus and colleagues (1976) indicates that 
PAH compounds can leach from processed oil 
shale and can migrate with the saline water. 
Depending upon shale age and retorting 
process, between 20 percent and 40 percent of 
the PAH in benzene extracts of spent shale 
can enter the percolating water. The PAH 
content of this percolate could be as much as 
3 to 4 orders of magnitUde higher than 
that of the pristine ground or surface water 
in the area. The water pollution potent ial 
from commercial oil shale development becomes 
very real in view of the result ing large 
quantities of spent shale. The probability 
that compounds having blastomogenic or 
mutagenic properties will enter into the 
envi ronment from th is source warrants an 
intensive monitoring program and an in-depth 
study of the consequences of these compounds 
in the environment and on biological organ-
isms in the environment. 
Fate and Effect of PAH in the 
Aquatic Environment 
The fate of PAH in the environmental 
waters is affected by its physical and 
chemical characteristics and the physical, 
chemical, and biological factors of the 
environment. In pure water, 4 to 5 ring .PAH 
are nearly Insoluble (1 to 10 ng/l (Borneff 
and Knerr 1960», however, there is suff i-
cient evidence to suggest that the solubility 
of PAH can be increased by a wide variety of 
organic compounds (lactic acid, acetone, 
ethanol) that may be found in certain waters 
(Ekwall and Sjoblom 1952; Suess 1967). The 
majority of the PAH which exist in excess of 
its solubility is sorbed to surfaces. The 
transport and settling characteristics of the 
part icles play an important role in the 
d ispers ion and pers Istence of the PAH car-
r ied. 
There are two primary modes by which 
polycyc lic aromat IC hydrocarbons are de-
graded. These are phys lcal ox idat ion and 
biological degradation. The most important 
process, quantitatively, is photo-oxidation. 
The photodecompos it ion of BaP both in solu-
t ion and while adsorbed onto calcium carbon-
ate particles in a suspension has been 
investigated (Suess 1967). While pH and ionic 
strength of the water had no effect on BaP 
degradation, oxygen concentration, tempera-
t ure, illumi nat ion, and exposure time in-
creased the decomposition rate. This study 
led to the conclusion that BaP (and presum-
ably other PAH) degradation will fluctuate on 
a daily and seasonal basis and will occur at 
a faster rate in the upper layers of the 
water and decrease with depth. Also, it is 
expected that PAH in river, lake, and sea 
sediments will degrade physically very 
slowly, if at all, because of the lack of 
penetration of oxygen and radiat ion (Suess 
1967) • 
The decomposition of the PAH fraction 
that escapes physical oxidation is dependent 
upon the processes of biodegradation. A di-
vers ity of organisms (bacteria, fungi, and 
algae) are capable of PAH degradation (Walker 
and Colwell 1974; Walker et ala 1975a, 1975b) 
in laboratory and field studies, both in 
terrestrial (Lijinsky and Quastel 1956; 
Jobson et al. 1972, 1974) and marine (Barns-
ley 1975; Atlas and Bartha 1972) environ-
ments. 
There have been few studies to determine 
the response of freshwater organisms to PAH 
in their environment. Metcalf (1975) used a 
3-day model aquatic system to evaluate the 
ecological effects of BaP. Using the 
radiolabeled compound, it was demonstrated 
that BaP was accumulated and stored in the 
tissues of organisms from each trophic level. 
Bioaccumulation factors (the ratio of the BaP 
concentration in tissue to the BaP concentra-
tion in water) were for fish, 930; algae, 
5258; mosquito, 11.536; snail, 82.231; and 
Daphnia. 134,248. Some degradation of this 
compound to unknown polar compounds was 
observed. 
Marine organIsms have also been shown 
to accumulate BaP and other PAR (Lee et a1-
1972a, 1972b. 1976; Neff et ala 1976). Using 
r ad iolabe led compounds, the pathway of 
uftake. metabolism, and storage of PAR 
( 4C-Napthalene and 3H-BaP) in fish has been 
demonstrated (Lee et a1. 1972a). The pollu-
tants are taken up through the gills within 
minutes of expo~ure, they are metabolized in 
the liver. then the hydrocarbons are trans-
ferred to the bile and their metabolItes 
are excreted in the urine. The storage site 
of labeled hydrocarbons is the gall bladder. 
The major metabolic product of BaP was 7,8-
dihydro-7,8-dihydrobenzopyrene and of naptha-
lene was 1,2-dihydro-l,2-dihydroxynapthalene 
after 24 hours of exposure. Some organisms 
may not metabolize these compounds but rather 
are able to detoxi fy and excrete them when 
exposed for a relatively short period of time 
(Corner et al. 1973). The rate of release of 
the accumulated compound when the organism is 
placed in compound-free water also varies for 
dIfferent organisms; it may take as long as 
58 days for clams exposed to BaP (Neff et al. 
1976). 
Effect of Water and Wastewater 
Treatment on PAH 
The majority of the research to deter-
mine the effect of some water treatment 
processes on the removal of PAH has been 
performed by European investigators (see 
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Andelman and Suess (1970) for a complete 
review of the subject). Simple clarification 
was found inefficient in PAH removal, 
presumably because the colloidal mater ials 
which adsorb the PAH are too small to settle 
(Borneff and Fischer 1963). However, when 
flocculation precedes sedimentation, the 
removal efficiency of PAH from river water 
increases (Lawerenz 1967). The work of 
Borneff and Kunte (1964; 1965) indicated that 
the combination of rapid sand-filtration and 
chlorination or ozonation were not particular-
ly ef fect ive in reduc ing the concentra-
t ion of the three compound groups stud ied: 
BaP, carcinogenic PAH (BaP, 3,4-benzfluor-
anthene, benz (a)anthracene, 10,ll-benzfluor-
anthene and indeno(l,2,3-cd)pyrene) or total 
PAH (the five compounds above plus 11,12-
benzfluoranthene, 1,12-benzperylene, fluor-
anthene, and pyrene) in lake water (percent 
reductions for these three groups were: 0 
percent, 42 percent, and 19 percent, respec-
tively). The addition of activated carbon to 
the filter. however, gave greater reduction 
in concentrat ion of these three compound 
groups (99 percent, 69 percent, and 65 
percent reductions In BaP, carcinogenic PAH, 
and total PAH, respectively). 
Numerous studies have reported the 
effectiveness of oxidizing agents such as 
c.h lor ine and ozone, on the remova 1 of total 
PAH from water. Chlorinat ion (us ing hypo-
chlorite) does not significantly increase the 
removal of PAH using the typical disinfection 
time (one half hour) and dosage (0.3 - 0.5 mg 
C12/l) (Graf and Nothhafft 1963). However. 
disinfection with gaseous chlorine in 
dose and contact periods commonly practiced 
in water treatment was found to yield a high 
removal of BaP (Reichert 1968a, 1968b, 
1968c). Using ultraviolet and infrared 
fluorescence spectra and mass spectroscopy, 
Reichert (1968a, 1968b, 1968c) has identified 
eight isolated derivatives of the reaction of 
BaP with chlorine dioxide. The majority of 
these (90 percent) are non-carcinogens 
(3,4-benzopyrene-l,5-dione; 3,4-benzopyrene-
5,8-dione, and 3,4-benzopyrene-5,10-dione). 
The residual derivatives have a lower car-
cinogenic effect than BaP (5-chloro-3,4-
benzopyrene, 5,8,10-trichloro-3,4-benzo-
pyrenes). Two isomeric dichloro-3,4-benzo-
pyrenes have also been identified but their 
carcinogencity is unknown. D is infect ion by 
chlorine dioxide may decrease the carcino-
genic hazard of polluted wastewaters, how-
ever, for the trace quantities (ng/l) of PAH 
normally present in groundwaters, chlorine 
dioxide is not an effective treatment because 
PAH cannot be removed in practically useful 
periods (Reichert 1968a). Experimental 
studies with ozone have shown it can be 
effective in removing up to 99 percent of BaP 
in aqueous solution after 30 minutes contact 
time (Borneff 1969); BaP can be resistant to 
degradation by ozone if it is adsorbed onto 
soil particles, which is generally the 
case. 
Fi It rat ion through act ivated carbon is 
the most effect ive conventional process for 
removal of PAH, though no known method has 
been found to reduce the concentration of 
carcinogenic PAH below 10 ng/l, a typical 
value for uncontaminated groundwater (Rei-
chert 1968a; Borneff 1969). 
Human Exposure to PAH and Health 
Hazard Assessment 
As a result of biosynthesis and anthro-
pogenic sources, BaP and other PAH are widely 
distrIbuted on this planet. Humans are 
exposed directly to PAH compounds in food, 
water, and air. It is postulated that 
concentrations of BaP exist on the order of 
10 to 20 ~g/kg of dry organic substance (Graf 
and Diehl 1966). The concentration of 
carcinogenic PAH in freshwater ranges from 1 
ng/l in unpolluted groundwater to 25 ng/l for 
treated surface water to greater than 100 
ng/l for very contaminated surface water 
(Borneff and Kunte 1964). Numerous reports 
have identified carcinogenic PAH in urban air 
and In cigarette smoke (Hoffmann and Wynder 
1962) adsorbed to particulates which can be 
inhaled by man. The organisms of the lower 
trophic levels, zoo- and phytoplankton and 
worms have all been shown to contain carcino-
genic PAH. These organisms serve as the food 
source and also a source of PAH for ed i ble 
f ish and shelH ish from wh ich PAH can reach 
man. The existence of carcinogenic PAH in 
cooked meats has also been demonstrated 
(Bailey and Dungal 1958; Dungal 1961; Kray-
bill 1969). 
Obviously, humans are exposed to carcino-
genic PAH from many sources. The ef fect on 
human health of this exposure is very diffi-
cult to determine because the presence of so 
many uncontrollable factors complIcates 
analys is. The general consensus of re-
searchers working with experimental animals 
IS that repeated exposure to carcinogenic 
chemIcals is more effective than an equi-
valent single dose, and that there is a 
potent ial danger of cont inuous exposure to 
carcInogenic PAH introduced into the gastro-
intestinal tract by water and food, even at 
low concentrat ions (Payne and Hueper 1960; 
Poe 1 1963). Many investigators believe that 
there is no safe level of PAH to which 
humans can be exposed without adverse effects 
(Ilnltsky and Varshavskaya 1964), and there-
fore some suggest that its threshold be set 
pract ically at zero (Gerarde 1960). Th is 
recommendation is impractical because of the 
natural background concentrations of PAH in 
the environment from biosynthesis. It is 
agreed that the presence of carcinogens in 
the air, food, and water are undesirable, 
however, a low level of exposure appears to 
be inevi table. Therefore, cons iderat ion 
should be given to avoid increaSing the level 
of carcinogeniC PAH to which humans are 
exposed, where possible. 
Monitoring CarCinogens in. the Environment 
The early detection of carcinogens in 
the environment is necessary in order to be 
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timely in organiz ing public and pr i vate 
support for their removal. The Early Organic 
Detect ion System (EODS) under the au thor ity 
of the Ohio River Valley Water Sanitation 
Commission is an example of such a monitoring 
program (Hadeed 1978). In response to 
studies which linked cancer mortality to 
chemicals in the Ohio River drinking water, 
this system was established to develop stream 
quality criteria for certain compounds that 
may affect public health or the envi ronment 
and to i nst igate regulatory programs to 
control such compounds in point source 
discharges. The degradation of water quality 
in several rivers used as drinkIng water 
sources in the United States warrants this 
type of program. In order to avoid th is 
happening in relatively unpolluted river 
systems, the magnitude of impact of a poten-
tial pollution source must be estimated 
prior to its existence. 
Mutagen/Carcinogen Screening Systems 
The water pollut ion potent ial of spent 
oil shale residues is a major concern regard-
ing the environmental impact of oil shale de-
velopment (Ward 1971; Dassler 1976; Schmidt-
Collerus et al. 1976; Slawson 1979; Cleave 
1979). Salts, trace elements and organics 
includ ing carcInogenic PAH, that may leach 
out of spent shale asa result of weathering 
and into surface and groundwater may pose a 
serious problem to public health and the 
environment. Despite the relatively low 
concentraton of the benzene-soluble organics 
ins pen t s ha Ie (200 -200 0 ppm (Sc hm id t-
Collerus 1974», the large quantities of 
spent shale that will be produced during a 
day of full production (estimated at one 
facility, the White River Shale Project, to 
be 86,000 metric ton (Slawson 1979», will 
contain 17-170 metric ton of benzene-soluble 
materials per day. Schmidt-Collerus (1974) 
found that 20-40 percent of the total ben-
zene-soluble organic matter in shale can be 
leached by water and that most of the car-
cinogens in the shale were dissolved and 
concentrated in the salt residue. Therefore, 
it would be appropriate to perform additional 
bioassays to assess the carcinogenic hazard 
of spent shale. 
The long-term, expensive animal bio-
assays that were at one time the rule, are 
presently being preceded with a series of 
short-term, in vitro, bioassays several of 
which are listed in Table 1. The advantages 
of using these new bioassays for initial 
screening are their relatively low cost, 
simple procedure, reproduc ib ili ty and accu-
racy in detect ing environmental carc inogens 
(Table 2). 
Recent scientific advancements in 
chemical carcinogenesis and in molecular 
biology h ave suggested that carc inogen ic 
chemicals activated by either chemical or 
biochemical means are frequently mutagenic 
(Miller and Miller 1971; Vogel and RBhrb"orn 
1970; Strong 1976; Mueller et al. 1978). 
These two fields had previously remained 
distinctly separate because the indicator 
organisms used to detect mutagens were not 
capable of transforming a procarcinogen to 
its act ive form. Provided suitable act iva-
t ion can be achieved in an in vitro or in a 
host-mediated assay, mutagenesis appears to 
be a useful indicator of carcinogenicity 
(Legator 1972; Garner et al. 1972; Ames et 
al. 1973; McCann et al. 1975). The results 
of comparat ive stud ies on the accuracy and 
sensitivity of these short-term tests are 
presently being compiled with the ultimate 
goal of developing a standard screening 
procedure for exist ing chemicals of unknown 
hazard and for the multitude of chemicals 
contlnually being created. 
The preliminary results of these 
comparative studies have revealed that a few 
short term submamallian mutagenicity tests 
are sufficiently accurate to use prior to 
mammahan testing. Bridges (1976) has 
outlined a three tier system for chemical 
carcinogen screening (Figure 1). Most 
chemicals and environmental samples would be 
tested by one or more of the short term, 
submammalian assays in the fIrst tier. These 
assays are used to assess a wide variety of 
genetic damage, including DNA mutation 
and chromosomal aberrat ion. Damage to DNA 
leading to heritable changes may be important 
to man not only because of the correlat ion 
with carcinogenicity, but because it may also 
cause hereditary disease (Legator 1972; 
Drake et al. 1975). Both the outcome and the 
priority of the substance would determine the 
next phase of test ing. A negat ive outcome 
would allow that compound (sample) to pass if 
it is of low priority (i.e. few humans will 
be exposed to it and precautions can be 
made to protect them). A negat ive outcome 
would be further tested in tier 2 if the 
compound is of high priority (I.e. a large 
number of humans will be exposed to this 
compound and may even consume it) to en-
sure against the occurrence of a false 
prediction. Those samples which gave a 
pos it ive response would either be rej ected, 
if a non-mutagenic substitute were available 
or further tested in tier 3, if not. The 
assays of tier 2 would include both long- and 
short-term tests involving in vitro and in 
vivo systems. Again the sample would be 
subjected to a battery of tests. A repeated 
negat ive response in tier 2 would allow the 
chemical to pass. A positive response would 
result in rejection if a non-mutagenic 
substitute IS available or further testing in 
tier 3 if it is a potentially valuable 
substance. In the third tier further testing 
using whole animal carcinogenesis assays 
could be performed, if necessary, to corrobo-
rate the mutagenic potential of the sub-
stance, however the primary objective of this 
stage is to evaluate, as quantitatively as 
possible, the hazards to humans from sub-
stances shown to be potentially carcinogenic 
In the first two tiers. Only compounds whose 
use or presence seems inevitable would be 
subject to thIS evaluation. A risk-benefit 
Table 1. Types of damage detected by currently employed mutagen screening systems. a 
Category 
Bacterial 
Fungal 
Plant 
Insect 
Screening System 
Orgar.ism 
typhimurium 
~~~~~ coli 
1!~~~~~ paludosa 
~~~~~ melanogaster 
juglandis 
Mammalian cell culture Chinese hamster 
Mouse lymphoma 
Intact mammal Mouse 
Rat 
Man 
Chromosome 
Domi-
nant 
Ie thal-
ity 
+ 
+ 
+ 
+ 
+ 
+ 
Trans-
loca-
tions 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Type of Damage Detected 
Aberrations 
Dele-
tions 
and 
dupli-
cations 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Non-
dis-
junc-
tion 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Gene Mutations 
For-
ward 
or re-
verse 
or 
both 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Mul-
tiple 
spe-
cific 
locus 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
In-
duced 
recom-
bina-
tion 
+ 
+ 
+ 
+ 
from Drake et al. (1975). copyright 1975 by American Association for the Advancement of Science, and 
presented here with their and the authors permission. 
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assessment could then be used to help deter-
mine the regulatory steps needed to reduce 
human exposure. 
The first tier screening tests play an 
e ssent ial role in th is system, because the 
scheme for further testing is based on their 
predictive value. The most successful assays 
currently 'under scrutiny are those that 
detect DNA damage by the induction of muta-
tions in bacteria. Reversion to prototrophy 
is generally believed to be the most sensi-
t ive type of assay, and there are currently 
two tests of this type in general use. These 
two screening assays utilize: the histidine-
requiring mutants of the Salmonella tlPhi-
murium/mammalian microsome system Ames 
test) and the DNA polymerase-deficient 
mutants of the Escher ich ia col i sys tem. 
Comparative tests have shown that both tests 
are good predictors of environmental carcino-
gens (Purchase et al. 1976) but each test has 
its individual strengths and weaknesses. For 
example, the ~ coli mutants are more sensi-
t ive than the ~ typhimur ium mutants are in 
detect ing mutagens that cause base-pair 
substitutions, but much less sensitive 
in detecting frameshift mutagens. The Ames 
test, on the other hand, can detect a wider 
range of chemical mutagens, because it 
provides strains which respond to both 
base-pair substitution and frameshift muta-
gens (Bridges 1976). Since the purpose of 
this investigation was to provide an initial 
survey of the carcinogenic/mutagenIc hazard 
of spent shale leachates and because the Ames 
test has been successful in detect ing known 
PAH (McCann et al. 1975) and mutagens in 
petroleum, petroleum products, and effluents 
(Epler et al. 1978a, 1978b; Rubin et al. 
1976), it was the preferred assay. 
The Ames Test 
The data compiled for validation of the 
Ames test by McCann and coworkers (1975) are 
shown in Table 3. Overall, the test correct-
ly identified 90 percent (158/175) of the 
carcinogens as mutagens and 79 percent 
(49/62) of the non-carcinogens as non-muta-
gens. For the classes of compounds found in 
petroleum, its products and by-products 
(including spent oil shale), the predictabil-
ity was 96 percent accurate (85/88) for 
carc inogens detected as mutag.ens and 72 
perc-=nt (18/25) for non-carcInogens not 
mutagenic to bacteria. An independent 
Table 2. Operational characteristics of mutagen screening systems. a 
Test System 
Microorganisms with meta-
bolic activation: 
Salmonella typhimurium 
Escherichia coli 
Yeasts 
Neurospora crassa 
Cultured mammalian cells 
with metabolic activation 
Host-mediated assay with: 
Microorganisms 
Mammalian cells 
Body fluid analysis 
Plants: 
Vicia faba 
~s~ia paludosa 
Insects: 
Drosophila me1anogaster: 
Gene mutations 
Chromosome aberrations 
Mammals: 
Time to 
Run Test 
I 
Operating 
Costsb 
Initial 
Investment 
Costs 
Relative East of Detectionc 
Gene Mutations 
Chromosome 
Aberrations 
-----i-------t--------r------------r---------- .-
2 to 3 days 
2 to 3 days 
3 to 5 days 
1 to 3 weeks 
2 to 5 weeks 
2 to 7 days 
2 to 5 weeks 
Variable 
3 to 8 days 
2 to 5 weeks 
2 to 7 weeks 
2 to 7 weeks 
Very low Low Excellent 
Very low Low Excellent 
Very low Low Good 
Moderate Moderate Very good 
Moderate to high Moderate Excellent to fair 
Low to moderate Low to moderate Good 
Moderate to high Moderate Unknown 
Variable Low to moderate Variable 
Low 
Low to moderate 
Moderate 
Moderate 
Low 
Moderate 
Moderate 
Moderate 
Potentially excellent 
Good to excellent 
Unknown 
Good 
Unknown 
Good 
Relevance unclear 
Good to excellent 
Dominant lethal mutations 2 to 4 months Moderate to high Moderate 
Translocations 5 to 7 months Moderate to high Moderate 
Unknown 
Potentially very .good 
Blood or bone marrow 
cytogenetics 
Specific locus mutations 
1 to 5 weeks Moderate Moderate Potentially good 
2 to 3 months High to very high High to very high Unknown 
aTaken from Drake et al. (1975), copyright 1975 by American Association for the Advancement of Science, and 
presented here with their and the authors permission. 
bOperating costa vary widely depending upon the protocol specified and upon the number of substances tested 
simultaneously. Very approximately, very low is $1,00'0; low is $1,000 to $5,000; moderate is $3,000 to $10,000; 
high is $10,000 to $20,000; and very high is $25,000 upward (based on 1975 economics). 
cSince most of these test systems do not detect all classes of gene mutations or chromosome aberrations 
(see Table 1), these columns refer only to the detectable mutations. 
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examination of the Ames test conducted by 
Purchase and coworkers (1976) gave similar 
results. Ninety-one percent (53/58) of the 
carcinogens were mutagenic and 93 percent 
(58/62) of ·the non-carcinogens were not 
mutagenic. For the PAH compounds tested, in 
particular, 95 percent were correctly 
identified. Other researchers (Bartsch 1976; 
Commoner 1976a, 1976b) have attested to the 
predictive value of the Ames test. Addi-
t ional advantages of th is assay are the 
tentative indication that a quantitative 
relationship exists between carcinogenic and 
mutagenic potency (Meselson and Russel 1977) 
which is especially shown for a number of PAH 
(Teranishi et al. 1975), and the apparent 
suitability of the test to analyze complex 
mixtures (food, human body fluid, hair 
dyes) • 
Although additional data are still being 
accumulated on the accuracy of the Ames test, 
the current estimate is that the test can 
correctly predict the carcinogenicity or 
non-carcinogenicity of 90 percent of the 
compounds tested. That means that there are 
some chemicals that are carcinogenic but will 
not be detected by the assay (false nega-
t ives), and some chemicals that will be 
incorrectly identified as carcinogens (false 
pos it ives). Th is is part of the compromise 
that is to be expected when using a short 
term screening test. The short term assays 
are to be used only as a preliminary step 
( the fir s t tie r ) 0 f the com p 1 e t e t est in g 
procedure. There is some question, however, 
about the certainty of the number of false 
positives implicated by this test. McCann 
and Ames (1976) believe that many of the 
Three Tiers for Carcinogen Screening 
MICROBIAL & PLANT ASSAYS } 
GENE MUTATION: 
-fORWARD AND REVERSE 
-uNA REPAIR 
CHROMOSOMAL ABERRATION: 
-GENE CONVERSION 
-M I TOTI C RECOMB INA TI ON 
TIER 1 
non-mutagenic 
substitute 
available 
/ 
REJECT 
potentially 
valuable 
substance 
TIER 3 
TIER 2 
low consumption 
high 
consumption ~ 
PASS 
INSECT & MAMM~L I AN (I N VITRO 
AND IN VIVO) ASSAYS 
PASS 
GENE MUTATION: 
-DNA REPAIR 
-LETHAL MUTATION 
CHROMOSOMAL ABERRATION: 
-CHROMOSOME LOSS 
-MITOTIC RECOMB I NATION 
-LETHAL MUTATION 
-HERITABLE TRANSLOCATION 
non-mutagenic substitute available 
"" 
REJECT 
{ 
MA~MALIAN TESTS & RISK 
[VALUATION 
Figure 1. Hierarchical testing scheme for identifying mutagens and carcinogens. Three-tier 
approach adapted from Bridges (1974). 
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so-called "false" pos it ives detected by the 
Ames test will eventually be shown to be 
carcinogens. This has already been shown 
wi th the Ames test mutagen (and now proven 
animal carcinogen), furylfuramide (a food 
additive previously used in Japan), that had 
given negative results in two carcinogenicity 
trials (Miyaj i 1971a, 1971b). 
Ames Test Applied to Environmental 
Carcinogens 
The bacterial test system developed by 
Ames has been used primarily for testing pure 
compounds. In its extended application of 
screening for potential environmental carcin-
ogens, various substances of complex chemical 
Table 3. Summary of Ames test results indicating prediction accuracy for various chemical 
groups,a 
Class of Compounds 
Aromatic Amines 
Alkyl Halides 
Polycyclic Aromatics 
Esters, Epoxides and Carbamates 
Nitro Aromatics and Heterocycles 
Miscellaneous Aliphatics and Aromatics 
Nitrosamines 
~ungal Toxins and Antibiotics 
Mixtures 
Miscellaneous Heterocycles 
Miscellaneous Nitrogen Compounds 
Azo Dyes and Diazo Dyes 
Total 
aData taken from McCann et al. (1975). 
Percent Correctly Identifiedb 
o 25 50 75 100 
:::::::::;:::::::::::::::::::::::::::::::::: ::::::::::::::: :::;:: ::1 25 c 
111 
: .. :.: .. : ...... :.:.: ...... : ......... : .. : .. : .. : .. : .. : .. : .. : .. : .. : .,:":":":":. :.: .. : .. : ..... ~ ~ 
•••••••• : ••••••• : ••• :.: .......................................... : .• : 20 
.................................. " ........................ .. .. 
::::::::::::::::::::::::::::::::::: ::::::::::::::::::::::::::: :::::::;::. 26 
~~~~~~~~~~~~IB ~: H= :;::: ~:!: ~: ~: ~:~: ~: ~:~:~: ~: ~:~:::::::::! :;: ~::::: ~~ 17 
IB 
12 
~~~~~'"'"~~~~~~~~~~~~~ 
::::::::::::;:::::::: :::::::::::::::::::::::::::;::::::::::: ::;:;:;: ~21 
............ .................. ,. .. .. "II ... " ••••••••••••••••• ........ ;~. 
NTd 
2 
iNT 
7 
1~:::~:::~:::~:::~:::~::~:::~:::~:::~:::~::~:::~:::~:::~:;:~.::~:::~;:;~::;~;:~:::~:::~::~~9~ 
14 
r-______________ ~I 3 
! 
::: :=::::::::;::;::;::::::;:::::::::::;:::;: ~::::::::;:::::::::: 3175 
I 162 
bThere are two bars for each class of compounds; the stippled one refers to the known carcinogens of that 
class and the blank bar refers to the non-carcinogens, 
number appearing at the right of each bar indicates the number of different compounds assayed. 
dNT means no chemicals were assayed from that group. 
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composition have been fractionated and 
assayed. Mutagens have been detected in many 
types of environmental mixtures: tobacco 
smoke condensates (Kier et al. 1974; Hutton 
and Hackney 1975); urban air (Pitts et al. 
1978); hair dyes (Ames et al. 1975); petro-
leum products, by-products, and effluents 
(Rubin et al. 1976; Voll et al. 1977; Rao et 
al. 1977; Commoner 1977; Chrisp et al. 1978; 
Epler 1979; Epler et al. 1978a, 1978b); 
insecticides (Grant et al. 1976); pesticides 
(Sh irasu et al. 1976); flame ret ardent 
addi t i ves (Blum and Ames 1977); ur ine (Dur-
ston and Ames 1974; Yamasaki and Ames 1977); 
surface and potable water (Simmon and 
Tardiff 1976; Pelon et al. 1977; Glatz et al. 
1978; Loper et al. 1978a, 1978b); and aqueous 
waste material (Commoner 1977; Ander et al. 
1977; Epler et al. 1978a, 1978b; Epler 1979). 
The Ames test has also been applied to 
extracts of organisms from industrially 
polluted terrestrial and marine environments 
(Barnes and Klekowski 1978; Parry et al. 
1976) • 
It is usually necessary to apply chemi-
cal techniques to fractionate these mixtures 
prior to biological testing. Many research-
ers have relied on the procedures originally 
provided by Swain and colleagues (1969) for 
fractionating cigarette smoke condensate. 
When this technique is applied to petroleum-
related products and by-products, it is found 
that the biologically act ive chemicals are 
found with the basic and neutral fractions 
(Epler et al. 1978a; Rubin et al. 1976; Rao 
et al. 1977; Kier et al. 1974). Epler and 
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coworkers (l978a) suggest that the mutagens 
(and carcinogens) responsible for this 
act iv i ty in the bas ic fract ion could be 
quinoline, substituted quinolines, alkyl 
pyridines, acridine, napthyl-amines and/or 
aromatic amines. In the neutral fraction, 
the compounds implicated are benzanthracenes, 
dibenzanthracenes, substituted anthra-
cenes, benzopyrenes, benzofluorenes, pyrene, 
substituted pyrenes and/or chrysenes. 
Limitations of the Ames Test 
The validat ion process for determining 
the applicability of the Ames test for 
environmental screening of mutagens has 
encountered several problems. Several 
researchers have noted that their results 
could be biased as a function of sample 
collect ion and storage, or that art ifacts 
could be generated by the extraction and 
fractionation procedures (Epler et al. 
1978a). A number of biological variables 
also may affect the outcome of the assay 
(Epler et al. 1978a). For example, a mutagen 
present in one sample may go undetected due 
to the interfering toxicity of another 
compound (Ames et al. 1975), or the choice of 
inducer for liver enzymes could be inappro-
pr iate to act ivate certain compounds (Ames 
et al. 1975; Epler et al. 1978a; Bartsch 
1976). Finally, the nature of the inter-
actions (i.e. co-mutagenesis) of two or more 
mutagens in solution has received limited 
attention, and its effect on the response of 
the Ames tester strains is only beginning to 
be known. 
MATERIALS AND METHODS 
Sample Extraction and Preparation 
Extracts of spent oil shale were obtained 
from Maase and Adams (1980) who studied two 
extraction procedures. The first method 
employed soxhlet extraction using organic 
solvent and separation techniques for easier 
identification and bioassay of compounds 
in the complex mixture; the second was 
actually a series of methods for obtaining 
and concentrating identifiable compounds in 
aqueous leachates of spent shale. A general 
outline of both methods follows. 
The purpose of the soxhlet extraction 
was to indicate the total quantity of muta-
gens which could be obtained from the shale 
matrix. A diversity of samples were obtained 
(in effect eluted from the sorbent shale) by 
varying the sequence of solvents, the compo-
sition of solvents in mixtures, and the 
extraction time. Most of the samples for 
mutagenici ty testing were obtained in meth-
anol after a period of extr ac t ion wi th ben-
zene, although a few samples were developed 
in pentane, or cyclohexane. The use of 
solvents other than methanol frequent-
ly elicited a toxic response during mutageni-
city testing (benzene) or were incompatible 
with the bioassay procedure due to volatiliza-
t ion (pentane) or hydrophobicity (cyclo-
hexane). Attempts were made to evapor-
ate the original solvent and redissolve the 
sample in dimethylsulfoxide (DMSO), however, 
this procedure met with little success; a 
majority of samples still showed toxicity or 
failed to become resolubilized. 
The potential for water to leach muta-
gens from shale was evaluated by providing 
extended contact of water with. shale in both 
an upflow column and in a large teflon-lined 
drum equipped with a motor-driven mixer. The 
organic compounds suspended in the water were 
then either concentrated on an exchange resin 
(XAD-2 and XAD-7, Rohm-Haas Co.) and eluted 
with solvents of varying polarity, or extract-
ed directly with organic solvent (liquid-
1 iquid ext raction). As with the organic 
solvent extracts obtained from the soxhlet, 
these samples were concentrated by either 
roto-evaporation or Kuderna-Danish concentra-
t ion. Thin-layer chromatography was used 
to further separate the components in these 
mixtures, if necessary. In the presentation 
of the results, the procedures used for 
obtaining the individual samples are out-
lined. 
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Mutagenicity Tests 
In applying the Salmonella/mammalian 
microsome test or Ames test (Ames et al. 
1973), the Salmonella typhimuriam mutant 
strains employed for the screening (provided 
by Professor B. N. Ames, U. C. Berkeley) were 
TA 98, 1537, 1538, and TA 100. Strain 
TA 1535 was also used initially but later 
excluded from general testing because it 
respopded to so few of the known mutagens 
(see Results Section). 
The microsomal enzyme fraction (S-9) was 
obtained from rat liver homogenate after 
induction with a polychlorinated biphenyl 
mixture, Aroclor 1254 (Ames et al. 1973). 
After initial attempts to obtain an active 
S-9 mixture failed due to high temperature 
denaturation, it was found that low enough 
temperatures could be maintained by the 
addition of a glass jacket to the tissue 
gr inding tube (see Figure 2) through which 
ice-cold water could circulate and by allow-
ing sufficient time to elapse (15 seconds) 
between successive passes wi th the pestle. 
The Salmonella strains employed were 
histidine-dependent due to a specific muta-
tion in the genes coding for this biosynthe-
tic pathway. They could have been reverted 
back to the ability to grow without histidine 
by exposure to various mutagenic agents. 
Strains TA 100 and 1535 are reverted by 
substances causing base-pair substitutions in 
their DNA and strains TA 98, 1537 and 1538 
are reverted by frameshift mutagens. Posi-
tive, or mutagenic, activity is defined by a 
response showing at least twice the number of 
revertant colonies as that appearing in 
solvent controls. It has been suggested that 
the numbers of revertants is correlated to 
carcinogenic activity (McCann and Ames 1976), 
and therefore the results are presented in 
terms of strength of mutagenicity. In 
order to compare the sensitivity of strains 
to mutagens, the response was normalized to 
the spontaneous revertant response. A ratio 
was calculated by dividing the number of 
revertant colonies resulting from assays of 
the test compound by the number of revertant 
colonies resulting spontaneously in the 
solvent controls. For each experiment 
conducted, the ratio was calculated and a 
mean value and standard error was determined 
for each chemical, strain, and concentration. 
The samples resulting from spent shale 
extraction were assayed using the standard 
plate incorporation assay over a wide concen-
tration range (representing from 0.1 g to 10 
g of spent shale per plate), with and without 
the addition of the S-9 fraction. For 
compar ison, the dose-response of several 
known PAH standards, some of which had 
previously been identified in spent shale 
extracts, were determined. 
A few minor modifications of the proto-
cal described by Ames and coworkers (1973) 
became standard procedure in this laboratory 
because they improved the interpretation of 
---+----STIRRING MOTOR 
(ELECTRIC DRILL 
OR HIGH TORQUE 
STIRRER) 
.. 
.----COOLING JACKET 
CIRCULATION OF 
COOLANT 
TEFLON PESTLE 
Figure 2. Schematic diagram of jacketed 
tissue homogenizer. 
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the assay: 1) the percentage of agar in the 
top agar was increased from 0.5 percent to 
0.75 percent, thereby speeding the hardening 
process and minimizing top agar slippage; 2) 
the bacteria used were always fresh overnight 
cultures because the overall sensitivity and 
response were improved slightly; 3) strain TA 
1535 was excluded rather than TA 1538 in 
screening unknowns because of the sensitivity 
of TA 1538 in detecting nitrogen-containing 
PAH (Hutton and Hackney 1975; Kier et al. 
1974), and 4) the concentration of S-9 used 
per volume of S-9 mix was increased over the 
recommended proportion (Ames et al. 1973) to 
100-150 ~l/plate. 
In addition to the plate incorporation 
assay two other techniques were attempted. 
In order to conserve a limited amount of 
sample the "well" test, introduced by Turner 
and coworkers (1978) was used. This method-
ology combines the advantage of the spot test 
(small quantity of chemical required per 
test) and that of the plate incorporation 
assay (allows incorporation of hydrophobic 
substances, i.e. PAH, into the agar, thereby 
increas ing the exposure of the bacter ia to 
the mutagens). The method differs from the 
plate incorporation method in that histidine 
and biotin are added to the molten minimal 
agar prior to plate pouring, thus eliminating 
the need for top agar. Then a small aliquot 
(0.1 ml) of tester strain culture (2 x 108 
cells) is spread evenly over the surface of 
the agar. Two 13 mm plugs are cut out on 
opposing sides of a single petri dish and 
plugged with 0.1 ml of molten well agar (same 
as top agar minus histidine and biotin). In 
one well only the test chemical solution (in 
various concentrations) is added; in the 
other well, an identical quantity of chemical 
is added along with 50 ]11 of S-9. The two 
wells are filled with well agar to the same 
level as the agar surface. A response is 
taken as positive if a distinguishable ring 
of revertant colonies appears surrounding the 
well but does not appear in the control 
plates (prepared as descr ibed above except 
that solvent alone is used rather than the 
chemical solution) • 
For assaying the chemical mixture in 
aqueous extracts of spent shale, a techniq'ue 
described by Saxena and Schwartz (1979) was 
employed. The aqueous sample is filter-
sterilized and used to make up the Vogel-
Bonner E media for the minimal glucose plates 
(see the original methods paper by Ames et 
a1. 1975). The test water composes 90 
percent of the total media volume and 20 ml 
of media is distributed to each petri dish 
(representing 'V 0.15 g of spent shale per 
plate). The bacteria and S-9 are added to 
the dish in the top agar as usual. The 
technique exposes the bacteria to all chemi-
cals present in the water. A positive 
response could be determined quantitatively 
as with the plate incorporation procedure. 
As mentioned, the soxhlet extracts of 
spent shale were taken in benzene and in 
methanol, whereas the known PAH compounds 
were dissolved in DMSO prior to mutagenesis 
assay. In order to assess whether the 
choice of solvent has an effect on mutagenic 
response, the known compounds (those which 
were soluble) were assayed in solutions of 
methanol. The use of benzene in the Ames 
assay is not recommended, but a bacterial 
tolerance limit to the toxic effect of the 
solvent was also determined in order to 
assess whether small quantities of benzene, 
which may contaminate the methanol during the 
second phase of soxh1et extraction, could be 
responsible for any observed toxic response. 
The potential complexity of determining 
mutagenic response to chemical mixtures was 
investigated by assaying two known PAR 
compounds at various concentrations (equi-
valent to 5, 10, 50 ~g each per plate) in a 
one-to-one solution (by weight) and in two 
other weight ratios: 10 percent compound A 
with 90 percent compound B and vice versa. 
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The response was compared to that of the 
single compound at the same concentration to 
which an appropriate amount of pure solvent 
blank was added. 
General procedure maintained for all 
tests included positive controls to test for 
S-9 activity, and blanks to test for solvent 
effect and for sterile technique. Four 
replicate plates were used initially for each 
compound or sample tested (coefficient of 
variance (C.V.) - 13.4 percent, n = 27), but 
two replicates were later used with little 
loss of precision (C.V. = 14.0 percent, n = 
22) . 
Exper iments on the known PAR compounds 
were conducted at least twice. Due to the 
limi ted amount of available sample, many of 
the unknown mixtures (90 percent) were 
assayed only once. 
RESULTS 
Mutagenicity Testing of Known Compounds 
Eighteen known polycyclic aromatic 
hydrocarbons (PAR) were assayed for muta-
genicity using the plate incorporation 
procedure of the Ames test. Eleven of these 
compounds have been identified in spent 
shale extracts (indicated by the * in Table 
4). The others are examples of nitrogen- and 
sulfur-containing PAR which could possibly be 
formed during fossil fuel combustion. The 
response of the Ames test mutant strains to 
the diversity of compounds represented by 
this group was used to evaluate the appli-
cability of this test for mutagenicity 
screening of spent shale extracts. To be 
suitable for this use, a test must consis-
tently distinguish between mutagens and 
non-mutagens with a low rate of false posi-
tives (non-mutagens detected as mutagens) and 
false negatives (mutagens not detected). The 
mutant strains must be sensitive to small 
concentrations of test compound and consis-
tently demonstrate the same dose-response 
curve. 
A unique pattern of mutagenic response, 
in terms of a particular strain sensitive to 
the mutagen and the shape and magnitude of 
the dose response curve, was demonstrated for 
each chemical mutagen. Examples of these 
characteristic patterns are shown in Figures 
3 and 4 for a strong carcinogen, benzo(a)-
pyrene (BaP) and a moderate carcinogen, 
benz(a)anthracene (BA) , respectively. The 
data presented in these figures indicate that 
strain TA 100 is the most responsive of the 
four strains to these two chemicals and that 
responsiveness also varies among the other 
three strains. Since the spontaneous rever-
sion rate peculiar to a strain enhances its 
ult imate response, the average response at 
each chemical concentration for a given 
strain was normalized to the average sponta-
neous response (solvent control) determined 
for each experiment (no. revertants per plate 
for each treatment/no. spontaneous rever-
tants); thus, a comparison of the relative 
response of each strain to mutagens could be 
made. This ratio, henceforth referred to as 
the revertant ratio or R.R., proved to be a 
simple way to determine a positive mutagenic 
response, which according to co-developers of 
the Ames test (McCann et al. 1975) is defined 
by R.R. ?: 2.0. 
The advantage of expressing the data in 
terms of the revertant ratio is demonstrated 
Table 4. Polycyclic aromatic hydrocarbons identified in spent oil shale extracts. 
Compound Name Symbol 
*Acridine 
Anthanthrene (dibenz(c,d,j,k)pyrene) 
*Benz (a) anthracene BA 
*Benzo(g,h,i)perylene BP 
*Benzo(a)pyrene BaP 
*Carbazole 
Dibenz(a,j)acridine 
*Dibenz (a, h) anthracene DBA 
*7,12 Dimethylbenz(a)anthracene DMBA 
*Fluoranthene F 
3-Methylcholanthrene 
"Perylene p 
Phenanthrene 
"Phenanthridine 
*Pyrene 
aDRr (1974) Source: Schmidt-Collerus (197Q). 
bDRr (1976) Source: Schmidt-Collerus et al. (1976). 
c 
Investigator 
DRra Colony c 
X 
X X X 
X X X 
X 
X X X 
X 
X 
X 
X X X 
X X X 
X X 
X X X 
X X X 
X X X 
X X X 
dColony (1974) Source: Atwood and Coomes (1974). 
Relative carcinogenic activity on mouse skin, +++ high, ++ moderate, + = weak, - inactive, 
source: Hoffman and Wynder, in Searle (1976). 
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Carcinogenic 
Potentiald 
+ 
+ 
+++ 
+ 
++ 
++ 
++ 
unknown, 
Figure 3. Dose response curves using mutant Salmonella 
strains TA 100, 98, 1537 and 1538 for 
benzo(a)pyrene. Each point represents 
the average value obtained from at least 
two replicates in at least two experiments. 
Figure 4. 
J 
Dose response curves using mutant Salmonella 
strains TA 100, 98 and 1537 for benz(a)-
anthracene. Each point represents the 
average value obtained from at least two 
replicates in at least two experiments 
in Figures 5 and 6 which are transformations 
of Figures 3 and 4, respectively. The 
transformed dose-response curves indicate the 
relative sensitivity of each strain and 
whether that strain can be used to clearly 
ident ify the compound as a chemical mutagen 
(R.R. > 2.0). In the figures plotted from 
the data transformation, TA 1537 is shown to 
be the most sensitive of all those strains 
which responded to either BaP or BA. The 
other strains show a lesser response and are 
therefore less reliable for clearly detecting 
these compounds as mutagens. 
The results of the Ames test assay of 
the standard PAH compounds (including anthra-
cene, a non-carcinogen frequently formed 
during combustion of fossil fuels) are 
compiled in Table 5. The values presented in 
this table are the average revertant ratio 
values per plate determined for the concen-
tration at which that strain responded 
maximally. The R.R. value given in paren-
theses is accompanied by the symbol(s), - or 
+ which indicate the relative magnitude of 
the R.R. value (thus relative mutagenic 
strength) according to the scheme in Table 
6. 
The data compiled in Table 5 illustrate 
several features of the Ames test which make 
25 
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it suitable for mutagenicity screening of 
PAH-containing samples. Fi rst, the combina-
tion of five mutant Salmonella strains allows 
the detection of a wide variety of chemical 
mutagens. Of the compounds for which the 
carcinogenic activity is known (Figure 7), 
the Ames test correctly identified 86 percent 
(6/7) of them and therefore the rate of false 
negatives was 14 percent (13-H dibenzo(a, i) 
carbazole, a weak carcinogen was not detect-
ed). Seventy-one percent (5/7) of the 
non-carcinogens were non-mutagenic, thus the 
rate of false positive was 29 percent (fluor-
anthene and perylene were detected as muta-
gens by one or more strains). In addition to 
the ability to detect carcinogens with good 
accuracy, a comparison of the relative 
carcinogenic activity (Figure 7) and muta-
genic activity (Table 5) demonstrates that 
the magnitude of the mutagenic response of 
the bacterial strains was closely correlated 
with the intensity of carcinogenic activity. 
Examples which display this correlation are 
the inactive carcinogens, acridine, anthra-
cene, carbazole, phenanthrene, and pyrene, 
which were non-mutagens; the weakly-to-moder-
ately active carcinogens, benz (a) anthracene, 
and dibenz(a,h) anthracene which were moder-
ately strong mutagens; and the highly active 
carcinogens, benzo(a)pyrene, and 7,12 di-
methylbenz(a)anthracene were strong mutagens. 
---+- TA 100 
-0- TA98 
-0- TAI537 
-b- TAI538 
.... 
o e ~ ~ 00 
Figure 5. 
CONCENTRATION OF BENZO(A)PYRENE I JI 9 / plate 
Transformed dose response curves obtained by normalizing the data presented in 
Figure 3 to the spontaneous reversion rate of each strain. Each point represents 
an average value from at least two replicates in at least two experiments. The 
thin vertical lines passing through each point indicate the range of standard 
error around the mean. 
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Besides indicating the carcinogenic 
act ivity of these compounds, the results in 
Table 5 suggest the most likely type of 
mutagen. Some of the compounds, for example 
benzo(a)pyrene and l-aminopyrene are general 
mutagens, i.e., they can cause base pair 
substitution and frame-shift mutations of 
various types, while others are specific to 
the class of mutations initiated. Benzo(ghi)-
perylene is one of the latter, and appears to 
only cause mutations in the specific sequence 
of bases found in the mutant TA 1537. 
The Ames test assay has thus been shown 
to be a useful tool for mutagen screening; it 
is a sensitive bioassay and may be used to 
detect some mutagens which are present in 
small quantities. The magnitude of the 
mutagenic response may give some indication 
of the carcinogenic activity of the compound, 
and the responding strains may be used to 
indicate the type of mutation the compound 
causes. 
Mutagenicity Testing of Spent 
Shale Extracts 
Four types of spent shale were used to 
obtain samples for mutagenicity testing. Two 
CII 
-
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0. 8 -0- TA 98 ~ ~ TAt537 0 
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of these shales were processed by the Paraho 
operation, one (Paraho A) by the indirect 
mode, the other (Paraho B) by the direct 
mode. The other two spent shales were 
processed by TOSCO and Union.l 
The results of mutagenicity screening of 
the extracts from these spent shales are 
compiled in Table 7. The same format that 
was used to present responding mutant strain 
and magni tude of mutagenic response for 
the PAR standards is repeated for the unknown 
mutagens in the shale extracts. Also in-
cluded in this table is a brief description 
of the procedures (extraction, concentration, 
and separation) used in obtaining each 
sample. 
lCommercial process names are used 
throughout the text for convenient reference. 
For more information about the physical and 
chemical properties of the four samples in-
vestigated see Maase and Adams (1980). The 
data reported should be judged as representa-
tive only of early surface retorting research 
and should not be considered reflective of 
commercial scale processed shales. 
t .. 
o e ~ ~ 00 
Figure 6. 
CONCENTRATION OF BENZ(A)ANTHRACENE. jJ 9 / plate 
T~ansformed dose response curves obtained by normalizing the data presented in 
FIgure 4 to the spontaneous reversion rate of each strain. Each point represents 
an average value from at least two replicates in at least two experiments. The 
thin vertical lines passing through each point indicate the range of standard 
error around the mean. 
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Table 5. Results of Ames test assay of polycyclic aromatic hydrocarbon standards. a 
Symbol Compound Name 
Ac ridine (2) b 
1-Aminopyrene (2) 
A Anthracene (2) 
4-Azafluorene (2) 
BA Benz(a)anthracene (3) 
BP Benz(ghi)perylene (3) 
BaP Benzo(a)pyrene (3) 
Carbazole (2) 
Dibenz(a,h)anthracene (3) 
13-R-Dibenzo(a,i)carbazole (2) 
Dibenzothiophene (2) 
1535 
c 
DMBA 7,12 Dimethylbenz(a)anthracene (4) -
F Fluoranthene (2) 
P Perylene (3) 
Phenanthrene (2) 
Pyrene (3) 
Thianthrene (2) 
Triphenylene (2) 
wlo S-9 
++(4.95) 
MMR 2.0 
+(2.36) 
MMR 2.0 
1537 
N.T. d 
N.T. 
++(4.6) 
MMR 12.5 
+++(9.76) 
MMR 5.0 
++++(22.43) 
MMR 2.5 
+(2.74) 
MMR 12.5 
+++(8.82) 
MMR 5.0 
+(2.53) 
MMR 2S. 
+++++(4S.14) 
MMR 2.5 
aData are presented as the revertant ratio, R.R., where 
R.R. total number of revertants 
number of spontaneous revertants' 
TA Strain 
1538 
+(3.77)e 
MMR 2.0 
++(6.45) 
MMR 6.45 
+(3.22) 
MMR S.O 
++(6.65) 
MMR 2.0 
+(2.62) 
MMR 2.0 
98 
+++++(39.48) 
MMR 2.0 
+++++(37.24) 
MMR 2.0 
(+) (1.94) 
MMR 25.0 
+++(8.08) 
MMR 5.0 
(+)(2.17) 
MMR 12.5 
+(2.32) 
MMR 200. 
(+)(2.17) 
MMR 12.S 
++(4.82) 
MMR 2.0 
100 
++(4. SO) 
MMR 2.0 
+ (3.32) 
MMR (10.0) 
+ (3.46) 
MMR 25.0 
++(4.39) 
MMR 5.0 
(+) 2.03 
MMR 2S.0 
+(2.42) 
MMR SO 
+(2.49) 
MMR 2S. 
determined for at least two experiments for mutagens. Unless indicated the R.R. is calculated from data for re-
sponse with metabolic activation (S-9). 
bNumber in parentheses indicates minimum number of experiments conducted to obtain R.R. value reported for 
compound. 
CSymbols are used to indicate relative mutagenic strength. refer to Table 6. 
dNumbers refer to revertant ratio, R. R. 
;~ indicates toxicity at high concentrations of sample. 
N.T. 2 not tested. 
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Table 6. Description of symbols used to indicate relative mutagenicity. 
Symbol 
Average 
Revertant Ratio 
Value 
<2.0 
Interpretation 
(+) 
+ 
>2.0 rang~ng <2.0 or 
<2.0 rangIng >2.0 
2.0 - 4.0 
No mutagenic response 
Questionable mutagenic response 
Weak mutagenic response 
Moderate mutagenic response 
Strong mutagenic response 
++ 
+++ 
++++ 
+++++ 
4.0 - 8.0 
8.0 - 16.0 
16.0 - 32.0 
>32.0 
The results of Ames test assays indicate 
that mutagens are present in each of the four 
types of spent shale and that mutagens can be 
obtained by a variety of different extraction 
methods. In general, these mutagens require 
metabolic activation (addition of enzyme-
induced S-9) for their detection as mutagens. 
The repeated response of TA strains 1537, 
1538, and 98, indicate that many of these 
mutagens cause frame-shift substitutions of 
bases in bacterial DNA. There were fewer 
base-pair substitution mutagens detected in 
these samples. In addition, a toxic response 
was common and was usually associated with 
the solvent, benzene, in the sample but not 
always (Paraho A #2, Paraho B #6, Union #3). 
This toxic response may have obscured the 
detection of mutagens in these and other 
samples (Paraho A #5, Paraho B #5, Tasca #4). 
Attempts to separate the complex mixtures for 
the purposes of removing the chemicals (or 
solvents) responsible for the toxic response 
and of allowing more accurate detection and 
identification of chemical mutagens were 
unsuccessful. When thin layer chromatography 
was applied to certain mixtures which had a 
lot of mutagenic activity (Paraho B #1, TaSCa 
#2, Union #1), the mutagenic activity of the 
fractions (Paraho B #3, TaSCa #3, and Union 
#2, respectively) was weak or non-existent. 
The weak response may indicate that the 
compounds present are weak mutagens and/or 
they are present in low concentrations (i.e. 
poor recovery and subsequent dilution of 
sample) • 
Table 7 also summarizes some of the 
attempts to obtain mutagens in aqueous 
leachates of shale. The various methods of 
concentration using sephadex and XAD resins 
worked poorly in this regard resulting in 
questionable mutagenic activity (Union #3, 
#5). The attempts to use the aqueous 
sample in the agar media were also unsuccess-
ful (Union #4). 
These general results were found for all 
four sources of spent shale. Although 
inconsistencies in extraction procedure and 
sample preparation prevent specific compari-
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Very strong mutagenic response 
Extremely strong mutagenic 
response 
sons in the mutagen composition of the spent 
shales, the technique used on individual 
shales can be compared in terms of their 
yield of mutagens. 
Paraho A spent shale was subjected to 
two contrasting extraction regimes. When 
extracted for a short period (1 day) by each 
of two solvents (benzene followed by meth-
anol), the sample showed frame-shift mutation 
activity (Paraho A #1). Another sample, 
extracted for a longer period (4 days), using 
the same combination of solvents, showed only 
a slight base-pair substitute type of muta-
genic activity (Paraho A #2, #3). The 
combination of these two samples (Paraho #4) 
resulted in the detection of the frame-shift 
ty'pe of mutagen only. 
The mutagenic response of samples of 
Paraho B shale was, overall, greater than 
that for Paraho A. af particular interest is 
the result of assay experiments with samples 
#1 and #2. These samples were extracted 
with methanol only without prior extraction 
wi th benzene. The mutagenic response is 
relatively strong, and no toxicity was 
observed. The chromatographic separation 
(TLC) of these samples also showed mutagenic 
activity (Paraho B #3). This activity was of 
lesser magnitude than the original sample as 
would be expected if the chemical creating 
the effect was diluted. The lower concentra-
tion of this compound or of others may 
explain the lack of response of strains TA 
1535, 1538, and 98. 
Sample #5 (Paraho B) was the only sample 
which had a definite positive response when 
assayed without S-9. In fact, the response 
was somewhat greater when S-9 was absent than 
when it was present, for those strains which 
responded in both instances. The toxicity of 
this sample at high concentrations was, in 
all likelihood, due to the quantity of 
benzene (20 percent) in the s'olvent mixture 
assayed. Benzene was toxic to the bacterial 
strains at concentrations exceeding between 5 
percent but composing less than 10 percent 
of the 0.1 ml aliquot solvent volumes added 
(Figure 8). 
Table 7. Results of Ames mutagenicity testing of spent shale extracts. a 
Spent Shale 
Type and 
Sample No. 
Paraho A 
111 
112 
113 
1/4 
1/5 
Paraho B 
III 
112 
113 
114 
++ 4.60 
+ 3.30 
N.T. 
+ 2.75 
li5 w/S-9 g N. T. 
w/o S-9 N. T. 
li6 N.T. 
In N.T. 
/l8 h N.T. 
Tosco 
111 
li2 
li3 
114 
Union 
Ifl 
li3 
/14 
115 
N.T. 
N.T. 
N.T. 
N.T. 
N.T. 
N.T. 
N.T. 
N.T. 
1537 
+ 3.54 
+ 2.74 
I!. 
+++ 9.75 
++ 5.73 
(+) 2.25 
++ 4.25 
++ 5.401!. 
++ 6.60 I!. 
(+) 
(+) 
+++10.43 
+++11.33 
++ 5.00 
(+) 
(+) 
TA Strain 
1538 
(+) 1.80 
+ 3.32 
I!. 
+ 2.85 
+ 3.40 
+ 3.76 I!. 
++ 5.67 I!. 
I!. 
(+) 
98 
(+) 1. 90 
N.T. 
+ Z.41 
N.T. 
+ 2.46 I!. 
I!. 
I!. 
+++11.54 ++5.07 
+++14.44 ++8.17 
+++11.90 + 3.99 
(+) 
100 
(+) 1. 76 
(+) 1.86 
(+) 
Extraction Procedureb 
Sox. Ext. one day with ~H followed by 
one day with MeOH, KD concentration, in 
MeOH 
Sox. Ext. four days with 0H followed by 
four days with MeOH, RE concentration, 
in MeOH 
Sox. Ext. four days with 0H followed by 
four days with MeOH, KD concentration, 
in MeOH 
Samples 112 and 113 combined. 
Sox. Ext. four days with 0H-MeOH solution 
1:5 by volume, KD concentration, in 
0H-MeOH 
Sox. Ext. three days with MeOH, KD concen-
tration, in MeOH 
Same as Itl 
TLC on silica gel of sample Ii 1, Rf= - elu ted 
with MeOH:p-Pioxane solution 1:1 by vol. 
Same as If} excep t Rf= - eluted wi th MeOH: P-Pioxane solut~on 1:4 by vol. 
Sox. Ext. days with 0H:MeOH solution 1:5 
by vol., KD concentration, in ~H:MeOH 
Sox. Ext. one day with 0H followed by one 
day with MeOH, RE concentration, in MeOH 
Sox. Ext. one day with 0H followed by two 
days with MeOH, in MeOH 
Sox. Ext. one day with Pentane, KD concen-
tration, TLC on silica gel eluted 5 
fractions w/MeOH 
Sox. Ext. three days with 0H followed by 
five days with MeOH, RE concentration, 
in MeOH 
(+) Z.19 Same as III except KD concentration 
TLC on silica gel of sample liZ, eluted -
fractions with MeOH 
I!. Separation of sample liZ on A1Z03, eluted 
with 0H 
(+) Sox. Ext. one day with MeOH, KD concentra-
tion, in MeOH 
TLC on silica gel of sample III eluted -
fractions with MeOH 
AQ. Leach. filtered and passed through 
Sephadex gel, eluted with MeOH 
AQ. Leach. used in agar media preparation 
AQ. Leach. filtered and passed through 
XAD-2 resin eluted with MeOH 
of plate incorporation assays with rat liver homogenate (S-9) except where indicated, from at least 
two replicates. 
bAbbreviations used: Sox. Ext. Soxhlet Extraction: 0H Benzene; MeOH = Methanol; KD = Kuderna 
Danish; RE Roto-evaporation: TLC = Thin layer chromatography; Rf = Rf value; Vol. 
Volume; AQ. Leach. aqueous leachate. 
CSymbols are used to indicate relative mutagenic strength, refer to Table 6. 
dNumbers refer to revertant ratio, R. R. 
~I!. indicates toxicity at high concentrations of sample. 
N.T. = not tested. 
gw/o S-9 = assay performed without rat liver homogenate. 
hOf 5 fractions eluted from silica gel, only one Rf = 0.18 showed any mutagenicity. 
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When Paraho B spent shale was extracted 
in a similar manner to Paraho A (first with 
one solvent, benzene, and then with another, 
methanol), the samples contained few mutagens 
and these elicited a weak response (Paraho B 
#6 and #7). This result may have been due to 
the leaching of chemicals by the benzene or 
the toxicity of the remaining chemicals 
andlor solvent masking the mutagenic re-
sponse. 
INACTIVE 
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ACRIDINE 
c2¢O I; ~I 
PERYLENE 
,,-- D C()[J 
ceo 
ANTHRACENE 
, "'" 09 I u u 
PHENANTHRENE 
Tasca shale was subjected to extraction 
by two solvents, first benzene followed by 
methanol. Strong mutagenic act ivi ty mostly 
due to compounds causing frame-shift muta-
tions (TA strains 98, 1537, and 1538), was 
observed i" these samples (TOSCD #1 and #2). 
The separalion procedures used to develop the 
components of these strongly mutagen samples 
were unsuccessful at further identifying 
which components were responsible for the 
~ H O-J) I I u 
CARBAZOLE FLUORANTHENE 
69 ~ "'" u u u "'" u "",I 
PYRENE TRIPHENYLENE 
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4-AZA-FWORENE DIBENZOTHIOPHENE THIANTHRENE 
Figure 7. Chemical structure and relative carcinogenic activity of the 18 polycyclic aroma-
tic hydrocarbons assayed in the Ames test. Data complied from Dipple (in Searle 
1976). 
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mutagenic activity, probably due to sample 
dilution and loss (TaSCa #3) and the presence 
of benzene (TaSCa #4). 
Mutagenic activity was detected in Union 
spent shale when it was subjected to short 
extraction periods with methanol (Union #1). 
Thin layer chromatographic separation of this 
sample and subsequent assay of fluorescent 
components gave no further information 
regarding the compound(s) responsible for the 
original activity. Three water developed 
samples of Union spent shale (#3, #4, and 
#5), in which various methods were applied to 
concentrate the sample and any mutagens 
therein, were only marginally successful. A 
weak mutagenic response was detected in 
two of the three samples, however the results 
are questionable without a repeat of this 
experiment. 
Mutagenicity of Chemical Mixtures 
The Ames test has been shown effective 
in detect ing a wide var iety of PAR, some of 
wh ich are present in the organic res idue of 
spent oil shale, as mutagens. The selecti-
vity and intensity of the mutagenic dose re-
sponse curve of the tester strains is seen to 
uniquely describe the PAR compounds assayed. 
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The environmental samples that are being 
screened for mutagenicity using this proce-
dure (e.g., surface waters, wastewater 
treatment plant effluent, and others) are 
generally mixtures of chemicals, some of 
which may be mutagenic and others not. Does 
the mutagenic response of the Ames test 
mutant bacterial strains reflect the presence 
of all mutagens in the mixture? If it does, 
is this response additive, i.e., does the sum 
of the parts equal the whole, or is it more 
or less than additive indicating the exis-
tence of antagonistic or synergistic inter-
actions? 
Assays of simple two component mixtures 
were performed to assess the capability of 
the Ames test to integrate the total muta-
genic potential of environmental samples. 
The chemicals paired in these mixtures were 
chosen from those in the list of standards 
which gave a unique mutagenic response when 
assayed with a particular mutant strain. The 
ideal mutagenic response to this mixture 
would be one that was additive. The hypothe-
sized response to this mixture was that 1) 
the Ames testing of a one-to-one mixture of 
components X and Y would result in a dose-
response curve which could be clearly 
distinguished from either of the dose re-
sponse curves of compounds X or Y alone, and 
o ~ ______ ~ ____ ~~ ______ ~ ______ ~ ____ -w 
Figure 8. 
o 2 4 6 8 to 
CONCENTRATION OF BENZENE Jig/plate 
Bacterial response to increasing doses of (a.l ml) of solution (solvent was DMSa). 
strains (TA 100, 98, 1537 and 1538) were 
and averaged. 
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the solute, benzene, in a fixed volume 
Data for each of four mutant Salmonella 
normalized to the DMsa control (blank) 
that 2) the dose response curve of the 
mixture (XY) would reflect the mutagenic 
potential of the individual compounds in an 
additive way. 
Ten pairs of compounds were assayed, in 
a total of eighteen experiments using the 
plate incorporation method to test this 
hypothesis. The resulting dose response 
curves for compound X alone, compound Y 
alone and the one-to-one (by weight) mixture, 
XY, were subject to chi-square analysis for 
interaction. This statistical test was used 
to determine whether the set of three dose-
response curves were distinguishable and if 
so, whether the dose-response attributable to 
the mixture was indistinguishable from the 
hypothetical response simply calculated by 
adding the responses of the individual 
components. In Table 8, the pairs of com-
pounds that were assayed, the particular 
mutant strain used in each experiment,· and 
the results of the chi-square analysis are 
shown. 
Lower case letters (a, b and c) are used 
to indicate those dose-response curves in 
the set of three which are statistically 
indistinguishable (a=O.Ol). A symbol is 
shared among those curves which are similar, 
a different symbol indicates a curve in that 
set which is statistically different from the 
others. To aid in the interpretation of these 
data and to allow an evaluation of the 
hypothesis regarding the shape of the dose 
response curve for mixtures assayed using the 
Ames test, the relative magnitude of muta-
genic strength of the individual compound 
when assayed with that particular mutant 
strain, is indicated using the symbols, + or 
-, used in Table 6. 
Figures 9 through 12 display the out-
comes that of these exper iments. The dose 
response curve that results when two mutagens 
are assayed together was found to be one of 
the following: 1) indistinguishable from the 
dose-response curves of either of the 
individual components, which are themselves 
indistinguishable (a,a,a), 2) distinguishable 
from the dose response curve of one of the 
individual components but indistinguishable 
from the other (a, b,a), or 3) distinguish-
able from the dose response curves of both of 
the individual components (a,b,c). The 
experimental outcomes corresponding to the 
first case (four pairs: #1, TA1537; 114, TA 
98; #5, TA 98; and #9, TA 98) are not helpful 
in testing the hypothesis (H1) because the 
fact that the response curves of the individ-
ual components are not statistically differ-
ent negates the ini t ial premise that the 
mutagens had unique dose response curves. 
However, these data serve to reject the 
hypothesis of an additive response (HZ) 
because the response to the mixture is not 
statistically different from either component 
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Table 8. Ames testing of solutions of two mu-
tagens .* 
TA Strain 
Pair Paired Compounds No. 1537 98 100 
Benzo (ghi) 
at +++** perylene, BP 
Dimethylbenz(a) 
anthracene, DMBA a +++ 
BP/DMBA a 
2 Benzo(a)pyrene, BaP a ++++ a +++ 
Perylene, P b +++++ b (+) 
BaP/P a a 
3 Benzo(a)pyrene, BaP a ++++ a +++ a++ 
Dimethylbenz(a) 
anthracene, DMBA b +++ b (+) b + 
BaP/DMBA a a a 
4 Benz (a)anthra-
cene, BA a (+) a + 
Dimethylbenz(a) 
anthracene, DMBA a (+) b + 
BA/DMBA a c 
5 Benz(a)anthra-
cene, BA a+t- a (+) 
Fluoranthene, F b + a (+) 
BAiF a,b a 
6 Dimethylbenz(a) 
anthracene, DMBA a +++ a (+) 
Perylene, P b ++++ b (+) 
DMBA/P c a,b 
7 Benzo(ghi) 
perylene, BP a +++ 
Perylene, P b ++++ 
BP/P c 
8 Fluoranthene, F a (+) 
Perylene, P b (+) 
F/P a 
9 Dimethylbenz(a) 
anthracene, DMBA a (+) a + 
Fluoranthene, F a (+) b + 
DMBA/F a a 
10 Benzo (a) pyrene , BaP a +++ a+t-
Fluoranthene, F b + b + 
BaP/F a c 
'l'Results of plate incorporation assays with rat 
liver homogenate (S-9). 
tSmall case letters (a,b,c), refer to the res,ults 
of chi-square analysis which was used to test whether 
the dose response curves of the set were distinguish-
able (different letters) or not (same letters) at <l .s. 
0.01. 
¥¥Symbols are used to indicate relative mutagenic 
strength, refer to Table 6. 
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Figure 9. Dose response curves for the mutant 
Salmonella strain TA 1537 to benzo(a)-
pyr ene, d imethy 1 benz (a) anth r acene and 
their one-to-one, by weight mixture. 
Each point represents the average of two 
experiments each of which had at least 
two replicates. The revertant ratio refers 
to the normalization of the data to the 
spontaneous reversion rate. 
Figure 10. Dose response curves for the mutant 
Salmonella strain TA 1537 to benzo(a)-
pyrene, perylene and their one-to-one, 
by weight mixture. Each dose of the 
mixture contains that quantity of both 
components. Each point represents the 
average of two experiments each of which 
had at least two replicates. The revertant 
ratio refers to the normalization of the 
data to the spontaneous reversion rate. 
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Figure 11. Dose response curves for the mutant 
Salmonella strain TA 1537 to dimethyl-
benz(a)anthracene, perylene and their 
one-to-one, by weight mixture. Each does 
of the mixture contains that quantity of 
both components. Each point represents 
the average of four replicates in one 
experim~nt. The revertant ratio refers to 
the normalization of the data to the 
spontaneous reversion rate. 
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Figure 12. Dose response curves for the mutant 
Salmonella strain TA 98 to dimethylbenz(a)-
anthracene, perylene and their one-to-one, 
by weight mixture. Each dose of the 
mixture contains that quantity of both 
components. Each point represents the 
average of four replicates in one experi 
ment. The revertant ratio refers to 
the normalization of the data to the 
spontaneous reversion rate. 
alone and therefore does not reflect the 
presence of the two mutagens. The outcome 
corresponding to the second. case (eight 
pairs: #2, TA 1537 and 98; 113, TA 1537, 
98, and 100; 118, TA 98; 119, TA 100, and 1110, 
TA 98) again is a rejection of the hypothesis 
(H2) because the dose-response curve for the 
mixture does not agree with the response that 
would be expected if the Ames test could 
integrate the total mutagens response of the 
two mutagens present. In fact, not only is 
the response to the mixture non-additive, it 
is shown to be statistically indistinguish-
able from one of the two mutagens in the 
mixture. As a likely explanation, an inter-
action exists whereby one chemical effective-
ly masks detection of the other. Generally, 
the component which "dominates" in the 
mixture is the mutagen which elicits the 
mutagenic response of greater magnitude 
(Figure 9). However, certain compounds (BaP, 
in particular) appear to dominate in a 
mixture even when they are the "weaker" of 
the two mutagens (Figure 10). 
The experimental outcomes of the third 
case (six pairs: 114, TA 100; 115, TA 1537; #6, 
TA 1537 and 98; #7, TA 1537; #10, TA 100), 
the results are of two types. While the 
three-way chi-square analyses indicated that 
the three dose response curves (X, Y, and XY) 
were all di fferent when analyzed together, 
the results of the two-way chi-square analy-
ses (X with XY and Y with XY) did not always 
substantiate this finding. For the majority 
of the pairs (4 of 6), the response curve, 
XY, was shown to be distinguishable from both 
of the other two curves when paired for 
analyses with it (Figure 11). These data 
support the hypothesis (HI) that the response 
to the mixture is different from the response 
to either of the components separately. For 
the other two pairs, the dose response curve 
of the mixture when paired for chi-square 
analysis with each curve from the individual 
components, could not be distinguished 
(Figure 12) though the three-way chi-square 
analysis showed the curves for the separate 
components were distinguishable. Based on an 
inspection of the data, this distinction of 
types would appear to be due to the magnitude 
and shape of the dose response curves of the 
individual components. The first type of 
response (a, b, c) occurs when the response 
varies greatly in magnitude and curve shape. 
The second type (a, b, ab) occurs when the 
two component curves are similar in magnitude 
and the curve of the mixture, being inter-
mediate between the two, is statistically 
indistinguishable from them because the 
difference between the actual response and 
the expected response generated in the 
chi-square analysis is small. The results 
from all six pairs provide further informa-
t ion in rejection of the hypothesized addi-
tive response (H2) to the mixture. 
To further evaluate the phenomenon of 
dominant interaction which was observed in 
more than half (8 of 14) of the experiments 
(the case I outcomes were disregarded because 
one cannot statistically support or reject 
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the existence of a dominance interaction 
when the dose-response curves of the individ-
ual components are not distinct), mutagens 
and non-mutagens combined in a one-to-one (by 
weight) solution were assayed. Given the 
previous behavior of the mutagenic response 
to the two-mutagen mixture, it was hypothe-
sized that the mutagen would dominate over 
the non-mutagen in the mixture in the 
same way. 
The results of nine experiments utiliz-
ing six pairs of compounds are shown in Table 
9. The manner in which the data are present-
ed follows that used in Table 8. Two types 
of outcomes were identified by chi-square 
analysis. These were: 1) The case in which 
all three curves were Indistinguishable 
within random experimental error (a,a,a), and 
2) The case in which the mutagen clearly 
dominated the response to the mixture (a, b, 
a). The results of the experiments were 
nearly evenly distributed between these 
categories. If the first type of response is 
disre[arded based on the fact that one cannot 
Table 9. Resul ts of Ames testing of solu-
tions of mutagen/nonmutagen pair.* 
Benzo(ghi)perylene, BP 
Dimethylbenz(a)anthracene, DMBA 
BP/DMBA 
Fluoranthene, F 
Anthracene, A 
F/A 
Benzo(a)pyrene, BaP 
P 
Anthracene, A 
Perylene, P 
A/P 
Dibenz(ah)anthracene, DBA 
Fluoranthene, F 
DBA/F 
Dimethylbenz(a)anthracene, DMBA 
Perylene, P 
DMBA/P 
TA 
1537 
a + 
a -
a 
a -
b ++++ 
b 
Strain 
98 
a t _** 
a (+) 
a 
a + 
b -
a 
a -
a (+) 
a 
a (+) 
b 
b 
100 
a + 
b 
a 
a++ 
b -
a 
a + 
a -
a 
*Resul ts of plate incorporation assays with rat 
liver homogenate (S-9). 
tSmall case 'letters (a,b,c), refer to the results 
of chi-square analysis which was used to test whether 
the dose response curves of the set were distinguish-
able (different letters) or not (same letters) at a ~ 
O.Ol. 
"''''Symbols are used to indicate relative mutagenic 
strength; refer to Table 6. 
statistically distinguish between the curves 
of the individual components and therefore 
cannot test whether one compound dominates 
over the other, all of the data remaining 
support the hypotheses of domi nance by the 
mutagen in a mutagen/non-mutagen mixture. 
The Ames test assays of solutions 
pairing mutagens with mutagens and mutagens 
with non-mutagens in a one-to-one (by weight) 
ratio has demonstrated a dominance inter-
action in which the response to the mixture 
is indistinguishable from that of one of the 
two components (generally the stronger 
mutagen). With environmental samples, 
however, the one-t o-one compos it ion is 
doubtful. What ratio of dominant to subordi-
nant component is necessary to maintain this 
interaction? It was hypothesized that the 
domination of the stronger mutagen would be 
insignificant when it composed 10 percent of 
the mixture. The paired compounds chosen to 
t es t th is hypothes is were those that demon-
strated a clearly defined dominance inter-
action. These pairs were BaP/DMBA (TA 100, 
98) and BaP/P (TA 1537). One component (X) 
of the pair was assayed at three concentra-
tions (0.5, 5, 50 llg/plate) while the other 
(Y) was kept constant (5 ~/plate). Then the 
components were switched and the process was 
repeated (a dose-response curve for Y was 
determined while X was kept constant). The 
results of a chi-square analysis for inter-
action for the three sets of dose-response 
curves are shown in Table 10. This analysis 
indicates that in two of the three experi-
ments (BaP/DMBA, TA 98 and 100), the dose 
response curve for the stronger mutagen 
(BaP), was indistinguishable from that of the 
stronger mutagen plus a constant quantity of 
the weaker mutagen (Figures 13 and 14). The 
ef fect of the dominant mutagen on the dose 
Table 10. Results of Ames test assay of non 
one-to-one, two component mixture. * 
TA Strain 
------Compound Pairs 1537 98 100 
BaP t ** a -H+ a++ 
BaP w/const DMBA a a 
DMBA b (+) b + 
DMBA w/const BaP c c 
BaP a ++++ 
BaP w/const P b 
P c +++++ 
P w/const BaP a 
*Results of plate incorporation assays with rat 
liver homogenate (S-9). 
tSmall case letters (a,b,c), refer to the results 
of chi-square analysis which was used to test whether 
the dose response curves of the set were distinguish-
able (different letters) or not (same letters) at CI :".. 
0.01. 
**Symbols are used to indicate relative mutagenic 
strength, refer to Table 6. 
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response curve of the lesser mutagen was to 
make it differ more from the dose response 
curve of that component alone as the ratio of 
stronger mutagen:weaker mutagen was in-
creased. The difference between the curves 
at the highest concentration tested does 
not support the hypothesis that the dominance 
interaction by the stronger mutagen would be 
insignificant when it composed 10 percent of 
the assayed mixture. 
The results of the BaP/P pair were more 
consistent with the stated hypothesis. In 
this pair, despite the fact that P is the 
stronger mutagen, BaP is the dominant in a 
one-to-one solution. This is seen in 
Figure 15 for solutions in which BaP composes 
50 percent or more of the total solution. 
However, when BaP is present as 10 percent of 
the solution, it no longer dominates the 
response. When P is assayed with a constant 
amount of BaP, the dominance interaction by 
BaP recurs (Figure 16). When BaP composes 10 
percent (25 llg BaP:125 llg P) of the solution, 
the response to the mixture is similar to 
that of SaP alone. These data are contra-
dictory, in one case (p with SaP constant, 
25 llg) BaP dominates when it is 10 percent, 
50 percent, or 90 percent of the solution, in 
the other case (SaP with P constant, 25 llg) 
SaP dominates when it is 50 percent or 90 
percent of the solution but not when it is 
only 10 percent (511g) of the mixture. It 
may, therefore, not be the composition in 
terms of the weigh t rat io of component X to 
component Y that is important in determining 
which compound is detected at the expense of 
the other, but the absolute concentration of 
each. This hypothesis appears to be support-
ed by the results shown in Figures 11 and 12. 
At low concentrations of SaP the response to 
the mixture is intermediate to that of the 
components, however, at ,a theshold concentra-
tion (12.5 - 25 llg BaP/plate when paired with 
P (Figure 10) and> 25 llg P/plate when paired 
wi th DMBA (Figure 11» the domi nance inter-
action is in effect. 
Solvent Effect 
Four solvents are recommended for use in 
the Ames test mutagenicity screening. These 
solvents are dimethylsulfoxide (DMSO), 
ethanol, methanol, and p-dioxane (Ames et al. 
1973). Since the PAH compounds chosen to 
assay as standards were all soluble in 
DMSO (solutions were 1 mg/ml with the excep-
tion of perylene which was 0.5 mg/ml), and 
because many investigators have used this 
solvent, it was assumed DMSO should also be 
used in the assays of known compounds. It 
was hypothes ized that the choice of solvent 
would have no significant effect on the 
mutagenic response of the mutant bacterial 
strains. Then, because the spent shale 
extracts were being obtained' in more polar 
solvents, methanol in particular, it was 
necessary to investigate the effect of 
the solvent and re-assay the componds, if 
possible, in methanol to determine whether 
the choice of solvent made a difference. 
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Figure 13. Dose response curves for the mutant 
Salmonella strain TA 98 to benzo(a)pyrene, 
dimethy16enz (a) anthracene and two non-one-
to-one mixtures of these components. 
Each dose of the mixtures contains that 
quantity of the first component listed 
plus 5 jJ g of the second component listed. 
Each point represents the average of 
four replicates from one experiment. The 
revertant ratio refers to the normali-
zation of the data to the spontaneous 
reversion rate. 
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Figure 14. Dose response curves for the mutant 
Salmonella strain TA 100 to benzo(a)pyrene, 
dimet6y16enz(a)anthracene and two non-one-
to-one mixtures of these components. 
Each dose of the mixtures contains that 
quantity of the first component listed 
plus 5 jl g of the second component listed. 
Each point represents the average of 
four replicates from one experiment. The 
revertant ratio refers to the normali-
zation of the data to the spontaneous 
reversion rate. 
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Figure 15. Dose response curves for the mutant 
strain TA 1537 to benzo(a)-
pyrene, perylene and two non-one-to-one 
mixtures of these components. Each dose of 
the mixtures contains that quantity of the 
first component listed plus 5 j.J of the 
second component listed. Ea point 
represents the average of four replicates 
from one experiment. The revertant ratio 
refers .to the ~ormalization of the data 
to the spontaneous reversion rate. 
125 
6 
5 
II) 
-g ~ 4 
o 
c: 
~ 
o 
.~ 
a:: 
I-
Z 
t:! 
0: 
W 
> 
W 
0: 
w 
~ 
a:: 
w 
~ 
3 
2 
o 
J 
TA9S 
DMSO 
o 25 50 75 100 
CONCENTRATION OF BENZ(A)ANTHRACENE. }J 9 I plate 
Figure 16. Dose response curves for the mutant 
Salmonella strain TA 98 to benz (a) anthra-
cene dissolved in two solvents, methanol 
and DMSO. Each point represents the 
average of two experiments each of which 
had at least three replicates. Revertant 
ratio refers to the normalization of the 
data to the spontaneous reversion rate. 
An attempt was made to dissolve 11 ·of 
the 18 compounds used as known PAH (BA, A, 
BaP, DBA, DMBA, F, BP, P, carbazole, pyrene 
and phenanthrene) in methanol for Ames 
testing. Three (BA, DMBA, and F) of these 
were sufficiently soluble for use in the 
assay. The· resulting dose-response curves 
were subject to chi-square analysis to test 
the hypothesis that solvent does not change 
the response to mutagens in solution. A 
summary of this analysis is shown in Table 
11. It can be seen that in the majority of 
the experiments (6/8) the solvent did have a 
significant effect (a ~ 0.01) on altering the 
response of the bacterial strains to muta-
gens. For the mutagen, BA, methanol had an 
effect of increasing the magnitude of the 
mutagenic response above that for the mutagen 
Table 11. Effect of solvent on mutagenic re-
sponse.* 
Fluoranthene in: 
Dimethylsulfoxide 
Methanol 
Dimethylbenz (a) anthracene: 
Dimethylsulfoxide 
Methanol 
Benz(a) anthracene: 
Dimethylsulfoxide 
Methanol 
1537 
a 
a 
a 
b 
TA Strain 
98 
a 
b 
a 
a 
a 
b 
t 
100 
a 
b 
a 
b 
a 
b 
.JCResults of plate incorporation assays with rat 
liver homogenate (S-9). 
t Lower case letters (a,b) refer to the results of 
chi-square analysis which was used to test whether the 
dose response curves of the pair were distinguishable 
(different letters) or not (same letters) at CL ~ O. 01. 
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dissolved in DMSO (Figures 16 and 17). 
With fluoranthene, however, methanol as 
a solvent had an effect on increasing 
the s ens it i vi ty of the assay (L e. greater 
magnitude of response at small concentrations 
of F), but at high concentrat ions of F 
dissolved in methanol, the solution was toxic 
to the bacteria. This result led to the 
test ing of F dissolved in the two other 
recommended solvents, p-dioxane and ethanol. 
The results of all of these experiments are 
shown in Figures 18 and 19. The data present-
ed here differ depending on strain used. The 
chi-square analyses for interaction indicates 
that the mutagenic response of TA 98 to F in 
DMSO, methanol, or p-dioxane are indis-
tinguishable within random experimental 
error. Methanol, on the other hand, has a 
pronounced effect on the response at high 
concentrations (Figure 18). The dose re-
sponse curves of TA 100 to F in the four 
solvents (Figure 19) show that the choice of 
solvent can be important; all of these 
dose-response curves are distinctly different 
(a. ~ 0.01). 
Solvent Effect on Dominance Interaction 
The pronounced effect of the solvent, 
methanol, on the response of TA 98 to fluor-
anthene prompted an experiment to test the 
effect of solvent on the mutagenic response 
to a one-to-one mixture of mutagens. In 
DMSO, BaP clearly dominates the response 
of TA 98 to the mixture of BaP and F (Table 
9). Would this dominance interaction by BaP 
be effective when assayed with F dissolved in 
methanol? The results of one experiment 
indicated that this dominance interaction may 
continue to exist, but appears to shift from 
dominance by BaP at low concentrations of 
both compounds (5 ~g F: 5 Vg BaP, per plate), 
to dominance by F at high concentrations (25 
}.lg F: 25 ~g BaP and 100 llg F:IOO Vg BaP, per 
plate) where the toxic effect of F is evident 
(Figure 20). The chi-square analysis of the 
five dose-response curves shown in the figure 
indicates that each curve, except for the 
pair BaP and BaP with F (in DMSO) is dis-
tinctly different. 
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Figure 17. Dose response curves for the mutant 
Salmonella strain TA 100 to benz(a)anthra-
cene dissolved in two solvents, methanol 
and DMSO. Each point represents the 
average of two experiments each of which 
had at least three replicates. Revertant 
ratio refers to the normalization of the 
data to the spontaneous reversion rate. 
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Figure 18. Dose response curves for the mutant 
Salmonella strain TA 98 to fluoranthene 
dissolved in four solvents, DMSO, ethanol, 
p-dioxane and methanol. Each point repre-
sents the average of four replicates in one 
experiment. Revertant ratio refers to the 
normalization of the data to the sponta-
neous reversion rate. 
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Figure 19. Dose response curves for the mutant 
Salmonella strain TA 100 to fluoranthene 
dissolved in four solvents, DMSO, ethanol, 
p-dioxane and methanol. Each point repre-
sents the average of four replicates in one 
experiment. Revertant ratio refers to the 
normalization of the data to the spont-
aneous reversion rate. 
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Figure 20. Dose response curves for the mutant 
Salmonella strain TA 98 to benzo(a)pyrene 
and fluoranthene (d issolved in DMSO) 
assayed separately and then together in a 
one-to-one, by weight mixture, and to 
benzo(a)pyrene and fluoranthene (dissolved 
in methanol) assayed separately and then 
together in a one-to-one, by weight mix-
ture. BaP was always dissolved in DMSO. 
Each point represents an average of two 
experiments each having four replicates. 
Revertant ratio refers to the normalization 
of the data to the spontaneous reversion 
rate. 
DISCUSSION 
Much controversy exists concerning the 
proper use of short term mutagenesis assays 
in screening environmental samples for 
potential carcinogens. Therefore this study 
made a special effort to characterize one 
particular assay, the Ames test, in terms of 
its strengths and limitations regarding its 
application to extracts from spent oil shale 
and petroleum-related effluents in general. 
Several PAR compounds were obtained for 
Ames testing initially to determine whether 
these procedures were correct and later to 
validate the assay. The consistency with 
which the magnitude and shape of the dose 
response curves could be reproduced using 
this assay, allowing a unique character iza-
t ion of each known compound, indicated that 
the procedures were reliable. Generally, 
when comparisons could be made, the data 
correlated well with those reported in the 
literature (McCann et a1. 1975; Kraybill 
1979; Belser, personal communication). For 
some of the stronger mutagens (l-aminopyrene, 
benz(a)anthracene and benzo(a)pyrene) our 
data were conservative (Table 12), whereas 
Table 12. Ames tes t results of selected poly-
cyclic aromatic hydrocarbons. a 
Compound Name 
I-amino pyrene 
Anthracene 
Benz (a) anthracene 
Benzo(a)pyrene 
Benzo(e)pyrene 
Dibenz(a,h)anthracene 
7,12 Dimethy1benz-
(a) anthracene 
Phenanthrene 
Pyrene 
Maximum b 
Revertant Ratio 
119 (TA 98) 
Relative 
Mutagenic 
StrengthC 
<1 (TA 100,98,1537,1538) 
16.5 (TA 100) ++++ 
++l-15.0 (TA 100) 
<1 (TA 100) 
2.5 (TA 100) 
9.1 (TA 100) 
<1 (TA 100,98,1537,1538) 
<1 (TA 100,98,1537,1538) 
+ 
a From McCann et al. (1975). 
b Revertant Ratio based on spontaneous values re-
ported in Ames et al. (1975); TA 100 (160); TA 98 (45). 
The strain or strains indicated in parentheses are 
those for which the response (revertant ratio) is 
reported. 
CSymbols: - inactive; + weak, ++ moderate, ++l-
strong, ++++ very strong, and ++++l- extremely strong 
mutagenic activity. All compounds which were mutagenic, 
required mammalian activation. 
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for the weaker mutagens the data agree. The 
discrepancy could be due to differences in 
the Viability of the bacterial strains or the 
liver microsomal fraction or in the failure 
to assay the concentration given the maximum 
I' esponse, all of wh ich affect the magnitude 
of the mutagenic activity observed. It is 
also possible that the spontaneous reversion 
rate determined in these experiments was 
different from that used to calculate 
the R.R. in Table 12. (As noted previously, 
the spontaneous reversion rate is increased 
by the presence of the liver homogenate and 
therefore the control used should be the one 
with S-9 added and no chemical.) 
Unfortunately, the three data sets 
(Tables 5, 12, and 13) do not overlap enough 
to allow more comparisons. More importantly, 
while the magnitude of response may vary, 
thi's has little effect on predicting the 
carcinogenicity of strong mutagens. The 
difficulty lies in distinguishing weak 
mutagens (and therefore likely weak carcino-
gens) from non-mutagens. This problem is 
seen in the two different categorizations 
(both weak mutagen and non-mutagen) for 
benzo(e)pyrene and pyrene (Tables 12 and 
13). 
The Ames test was used with mixed 
success in detecting mutagens in extracts 
from spent oil shale. The best results were 
Table 13 Mutagenicity of selected polycy-
clic aromatic hydrocarbons found 
in freshwater based on Ames test. a 
Compound Name 
1. Known Mutagens 
Benz (a) anthracene 
Benzo(a)pyrene 
Benzo(e)pyrene 
Chrysene 
Dibenz(a,h)pyrene 
II. Suspected Mutagens 
Benzo(ghi)perylene 
Pyrene 
TA 98, 
TA 98, 
TA 100 
TA 98, 
TA 98, 
TA 98 
TA 100 
Salmonella 
TA Strainb 
100 (TA 1537, 1538) 
100, 1537, 1538 
100 
100, 1537 (TA 1538) 
aFromKraybill et al. (1978). All compounds that were 
mutagenic required mammalian activation. 
bStrains in parentheses gave a weakly positive 
mutagenic response. 
obtained when soxhlet extraction was per-
formed using organic solvents. The first 
few samples obtained in methanol following 
benzene extraction (Table 7, Paraho #1-4; 
Tosco #1,2) were shown to produce dose 
response curves similar to those obtained for 
the known standards. Then, in order to 
get a more detailed description of the 
chemical composition of these extracts and 
the mutagenically-active fractions, separa-
tion techniques were employed. For the most 
part, these procedures did not enable 
further characterization of the mutagenic 
potency of these extracts. Di lution and 
solvent incompatibility appeared to be major 
problems. Subsequently, it was necessary to 
determine whether the mutagenic response 
to the complex mixtures being obtained prior 
to separation and purification was indicative 
of the total response contributed by each 
mutagenic component. 
The results of experiments using two 
component mixtures indicated that the re-
sponse of the bacterial strains to two 
mutagens assayed together was non-add it i ve. 
In the majority of cases, the response to the 
mixture was indistinguishable from the 
response to one of the components assayed 
separately (masking of one component in the 
presence of another, more dominant compound). 
In a few instances, the response to the 
mixture was intermediate to that of the two 
separate components. These 'observations 
conflict with other reported results. Epler 
and coworkers (1979) reported that the 
mutagenic activity of the neutral fraction of 
two different oils could be totally accounted 
for by the simple sum of the mutagenic activ-
ities of the four subfractions of the neutral 
fraction. This confirmation allowed com-
parison of the relative mutagenic strengths 
of these two oils by summing the act ivities 
from 14 fractions weighted according to the 
contribution each makes toward the total 
sample. The phenomenon of co-mutagenesis 
(Le., the enhancement of the mutagenicity 
of one compound by the addition of another 
compound which mayor may not be a mutagen), 
has also been reported with the Ames test 
(Sugimura 1977). The data presented in this 
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report indicate that the mutagenic potential 
of a mixed sample may be underestimated. 
While the spent shale extracts obtained 
using soxhlet extraction and organic solvents 
were assayed with fairly good success, with 
results indicating the potential for ground-
water pollution from mutagens present in 
spent shale, the assays of aqueous leachates 
did not support the observation by others 
(Schmidt-Collerus 1974) that they could be 
washed out of the shale. If mutagens were 
present in these leachates, they were either 
in very small concentrations or were lost 
during the procedures of extraction, purifi-
cation, and handling. Neither the standard 
Ames plate incorporation assay nor the two 
alternate methods for assaying aqueous 
samples indicated a sample having positive 
mutagenic activity. Another obstacle en-
countered was that one of the solvents, 
methylene chloride, which is recommended 
for use in sample separation, is a mutagen to 
the bacterial strains, thus preventing many 
fractions from being assayed. 
In conclusion, it can be said that muta-
gens, many of which are certainly carcinogens 
are present or at least can be formed from 
precursors in processed shale and that they 
can be extracted in organic solvents through 
soxhlet extraction. The failure to obtain 
positive evidence of mutagens in the aqueous 
leachates does not negate the possibility 
that they were extracted. Due to limitations 
in the quantity of spent shale with which to 
experiment and in the procedures used to 
COncentrate and prepare the extracts for 
testing, the compounds may have been present 
but in concentrations below the sensitivity 
level of the assay. This speculation is 
corroborated by the GC/MS data (Maase and 
Adams 1980), indicating that many of the PAH 
previously determined to be mutagenic are 
present in the aqueous extracts at the limit 
of their solubility (ng/l). It is likely, 
given this information, that further biologi-
cal testing of concentrated leachates from 
processed shale would successfully demon-
strate that the disposal of spent oil shale 
can be a source of mutagens to the environ-
ment through leaching. 
CONCLUSIONS AND RECOMMENDATIONS 
The results of Ames mutagenicity testing 
of extracts from spent oil shale waste 
derived from three different processes 
(Paraho, Tosco, and Union), indicate that 
mutagens can be collected andlor formed from 
precursors through soxhlet extraction using 
organic solvents. The high rate of carcino-
gen prediction demonstrated by this assay 
supports the speculation that carcinogeni-
cally-active compounds from spent shale can 
be expected to enter the envi ronment. The 
Ames test on these wastes failed to show 
evidence that .mutagens could be extracted in 
aqueous leachates from spent shale; however,' 
due to limited quantities of processed shale 
available for testing and inadequate tech-
niques to allow both concentration and 
biological testing of leachates, leaching of 
weathered spent shale should not be discount-
ed on the basis of these results as a poten-
tial pathway for mutagens andlor carcino-
gens to become mobile in the environment. 
The Ames test was found to be a sensi-
t ive and reliable indicator of potentially 
carcinogenic compounds in energy-related 
effluents as long as attention is given to 
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understanding the limitations of this short 
term assay. In particular, the information 
obtained through the course of this study has 
identified at least two areas of caution. 
First, the response of the Ames test to 
environmental mixtures in which chemical 
interact ions may occur is unpred ictable. 
The presence of mutagens may be masked by the 
dominating influence of another mutagen. 
This non-additive response almost necessarily 
means the screening assay will underestimate 
the potential hazard to humans. This prob-
lem can possibly be avoided by using a 
sophisticated fractionation scheme prior to 
testing. Second, the appropriate choice of 
solvents is essential for minimizing toxi-
city, chemical interactions, and excess 
mutagenicity, to the tester strain. 
Although the Ames test is highly recom-
mended as a screening procedure for identify-
ing sources of environmental carcinogens, its 
findings should always be confirmed by one or 
more short term assay to identify any false 
positive or false negative samples prior to 
in vitro and in vivo mammalian testing. 
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